,date,title,url
0,2000-08-17,海正药业半年报,/disclosure/listedinfo/announcement/c/600267_2000_1.pdf
1,2001-03-29,海正药业年报,/disclosure/listedinfo/announcement/c/600267_2000_0.pdf
2,2001-05-15,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/600267_2001_g.pdf
3,2001-05-16,海正药业关联交易,/disclosure/listedinfo/announcement/c/600267_2001_z.pdf
4,2001-08-14,海正药业半年报,/disclosure/listedinfo/announcement/c/600267_2001_1.pdf
5,2001-09-12,海正药业回访报告,/disclosure/listedinfo/announcement/c/600267_20010912_1.pdf
6,2001-09-14,海正药业半年报补充公告,/disclosure/listedinfo/announcement/c/600267_20010914_1.pdf
7,2002-03-01,海正药业年报,/disclosure/listedinfo/announcement/c/600267_2001_n.pdf
8,2002-03-09,海正药业信息披露管理办法,/disclosure/listedinfo/announcement/c/600267_20020309_4.pdf
9,2002-03-09,海正药业监事会工作规定,/disclosure/listedinfo/announcement/c/600267_20020309_3.pdf
10,2002-03-09,海正药业董事会秘书工作条例,/disclosure/listedinfo/announcement/c/600267_20020309_2.pdf
11,2002-03-09,海正药业董事会工作规定,/disclosure/listedinfo/announcement/c/600267_20020309_1.pdf
12,2002-04-02,海正药业治理纲要,/disclosure/listedinfo/announcement/c/600267_20020402_1.pdf
13,2002-04-17,海正药业总经理工作细则,/disclosure/listedinfo/announcement/c/600267_20020417_4.pdf
14,2002-04-17,海正药业治理纲要,/disclosure/listedinfo/announcement/c/600267_20020417_2.pdf
15,2002-04-17,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/600267_20020417_g.pdf
16,2002-04-17,海正药业股东大会议事规则,/disclosure/listedinfo/announcement/c/600267_20020417_3.pdf
17,2002-04-17,海正药业独立董事工作制度,/disclosure/listedinfo/announcement/c/600267_20020417_1.pdf
18,2002-04-18,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/600267_2002_1.pdf
19,2002-06-22,海正药业董事会专门委员会议事规则,/disclosure/listedinfo/announcement/c/600267_20020622_5.pdf
20,2002-06-22,海正药业董事会战略委员会实施细则,/disclosure/listedinfo/announcement/c/600267_20020622_4.pdf
21,2002-06-22,海正药业董事会提名委员会实施细则,/disclosure/listedinfo/announcement/c/600267_20020622_3.pdf
22,2002-06-22,海正药业董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/600267_20020622_2.pdf
23,2002-06-22,海正药业财务管理制度,/disclosure/listedinfo/announcement/c/600267_20020622_1.pdf
24,2002-06-27,海正药业股东大会会议资料,/disclosure/listedinfo/announcement/c/600267_20020627_1.pdf
25,2002-08-13,海正药业关联交易制度,/disclosure/listedinfo/announcement/c/2002-08-13/600267_20020813_1.pdf
26,2002-08-13,海正药业半年报,/disclosure/listedinfo/announcement/c/2002-08-13/600267_2002_z.pdf
27,2002-09-03,海正药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2002-09-03/600267_20020903_1.pdf
28,2002-09-14,海正药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2002-09-14/600267_20020914_1.pdf
29,2002-10-25,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-25/600267_2002_3.pdf
30,2003-03-22,海正药业年报,/disclosure/listedinfo/announcement/c/2003-03-22/600267_2002_n.pdf
31,2003-04-01,海正药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-04-01/600267_20030401_1.pdf
32,2003-04-24,海正药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-04-24/600267_20030424_1.pdf
33,2003-04-25,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-25/600267_2003_1.pdf
34,2003-04-26,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/2003-04-26/600267_20030426_g.pdf
35,2003-04-26,海正药业公司治理纲要,/disclosure/listedinfo/announcement/c/2003-04-26/600267_20030426_1.pdf
36,2003-07-05,海正药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-07-05/600267_20030705_1.pdf
37,2003-07-30,海正药业子公司综合管理制度,/disclosure/listedinfo/announcement/c/2003-07-30/600267_20030730_4.pdf
38,2003-07-30,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/2003-07-30/600267_20030730_g.pdf
39,2003-07-30,海正药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-07-30/600267_20030730_1.pdf
40,2003-07-30,海正药业公司治理纲要,/disclosure/listedinfo/announcement/c/2003-07-30/600267_20030730_2.pdf
41,2003-07-30,海正药业董事会工作制度,/disclosure/listedinfo/announcement/c/2003-07-30/600267_20030730_3.pdf
42,2003-07-31,海正药业半年报,/disclosure/listedinfo/announcement/c/2003-07-31/600267_2003_z.pdf
43,2003-10-25,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-25/600267_2003_3.pdf
44,2004-02-12,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2004-02-12/600267_20040212_1.pdf
45,2004-02-27,海正药业澄清公告,/disclosure/listedinfo/announcement/c/2004-02-27/600267_20040227_1.pdf
46,2004-03-09,海正药业重大关联交易公告,/disclosure/listedinfo/announcement/c/2004-03-09/600267_20040309_2.pdf
47,2004-03-09,海正药业年报,/disclosure/listedinfo/announcement/c/2004-03-09/600267_2003_n.pdf
48,2004-03-09,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-09/600267_20040309_3.pdf
49,2004-03-09,海正药业董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-03-09/600267_20040309_1.pdf
50,2004-03-26,海正药业2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-03-26/600267_20040326_1.pdf
51,2004-04-05,海正药业露2004年第一季度业绩预增提示性公告,/disclosure/listedinfo/announcement/c/2004-04-05/600267_20040403_1.pdf
52,2004-04-22,海正药业公告,/disclosure/listedinfo/announcement/c/2004-04-22/600267_20040422_1.pdf
53,2004-04-23,海正药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-04-23/600267_20040423_1.pdf
54,2004-04-23,海正药业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-04-23/600267_20040423_2.pdf
55,2004-04-24,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/2004-04-24/600267_20040424_g.pdf
56,2004-04-24,海正药业募集资金管理办法（草案）,/disclosure/listedinfo/announcement/c/2004-04-24/600267_20040424_4.pdf
57,2004-04-24,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-24/600267_20040424_2.pdf
58,2004-04-24,海正药业公告,/disclosure/listedinfo/announcement/c/2004-04-24/600267_20040424_3.pdf
59,2004-04-24,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-24/600267_20040424_1.pdf
60,2004-04-24,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-24/600267_2004_1.pdf
61,2004-04-28,海正药业澄清公告,/disclosure/listedinfo/announcement/c/2004-04-28/600267_20040428_1.pdf
62,2004-05-19,海正药业2003年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2004-05-19/600267_20040519_1.pdf
63,2004-06-08,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2004-06-08/600267_20040608_1.pdf
64,2004-07-24,海正药业第二大股东股权转让提示性公告,/disclosure/listedinfo/announcement/c/2004-07-24/600267_20040724_1.pdf
65,2004-07-27,海正药业股东增持持股变动报告书,/disclosure/listedinfo/announcement/c/2004-07-27/600267_20040727_1.pdf
66,2004-07-27,海正药业股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2004-07-27/600267_20040727_2.pdf
67,2004-07-31,海正药业关于控股股东增资扩股的提示性公告,/disclosure/listedinfo/announcement/c/2004-07-31/600267_20040731_1.pdf
68,2004-08-10,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-10/600267_20040810_2.pdf
69,2004-08-10,海正药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2004-08-10/600267_20040810_1.pdf
70,2004-08-10,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-10/600267_2004_zzy.pdf
71,2004-08-10,海正药业半年报,/disclosure/listedinfo/announcement/c/2004-08-10/600267_2004_z.pdf
72,2004-08-14,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2004-08-14/600267_20040814_1.pdf
73,2004-08-18,海正药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2004-08-18/600267_20040818_1.pdf
74,2004-08-24,海正药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-08-24/600267_20040824_1.pdf
75,2004-09-17,海正药业募集资金管理办法,/disclosure/listedinfo/announcement/c/2004-09-17/600267_20040917_2.pdf
76,2004-09-17,海正药业2004年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-09-17/600267_20040917_1.pdf
77,2004-09-17,海正药业2004年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-09-17/600267_20040917_3.pdf
78,2004-09-23,海正药业公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2004-09-23/600267_20040923_1.pdf
79,2004-10-23,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-23/600267_2004_3.pdf
80,2004-11-16,海正药业国有法人股转让获国资委批复的公告,/disclosure/listedinfo/announcement/c/2004-11-16/600267_20041116_1.pdf
81,2004-12-22,海正药业重大事项的进展情况公告,/disclosure/listedinfo/announcement/c/2004-12-22/600267_20041222_1.pdf
82,2004-12-23,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/2004-12-23/600267_20041223_g.pdf
83,2004-12-31,海正药业关于股东股权转让过户完成的公告,/disclosure/listedinfo/announcement/c/2004-12-31/600267_20041231_1.pdf
84,2005-03-22,海正药业重大关联交易公告,/disclosure/listedinfo/announcement/c/2005-03-22/600267_20050322_2.pdf
85,2005-03-22,海正药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2005-03-22/600267_20050322_3.pdf
86,2005-03-22,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2005-03-22/600267_2004_nzy.pdf
87,2005-03-22,海正药业年报,/disclosure/listedinfo/announcement/c/2005-03-22/600267_2004_n.pdf
88,2005-03-22,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-22/600267_20050322_4.pdf
89,2005-03-22,海正药业高管人员年薪制管理暂行办法（草案）,/disclosure/listedinfo/announcement/c/2005-03-22/600267_20050322_5.pdf
90,2005-03-22,海正药业董事会决议公告暨召开2004年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2005-03-22/600267_20050322_1.pdf
91,2005-04-09,海正药业董事会决议公告暨关于修改2004年度股东大会提案的公告,/disclosure/listedinfo/announcement/c/2005-04-09/600267_20050409_1.pdf
92,2005-04-15,海正药业2004年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-04-15/600267_20050415_1.pdf
93,2005-04-28,海正药业上市公司章程,/disclosure/listedinfo/announcement/c/2005-04-28/600267_20050428_g.pdf
94,2005-04-28,海正药业2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-04-28/600267_20050428_1.pdf
95,2005-04-28,海正药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-04-28/600267_20050428_2.pdf
96,2005-04-29,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-29/600267_20050429_3.pdf
97,2005-04-29,海正药业关于为控股子公司浙江省医药工业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2005-04-29/600267_20050429_2.pdf
98,2005-04-29,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-29/600267_20050429_1.pdf
99,2005-04-29,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-29/600267_2005_1.pdf
100,2005-06-13,海正药业2004年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2005-06-13/600267_20050613_1.pdf
101,2005-06-16,海正药业2004年度分红派息实施补充公告,/disclosure/listedinfo/announcement/c/2005-06-16/600267_20050616_1.pdf
102,2005-06-17,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-06-17/600267_20050617_1.pdf
103,2005-08-04,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-08-04/600267_20050804_1.pdf
104,2005-08-04,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-04/600267_2005_zzy.pdf
105,2005-08-04,海正药业半年报,/disclosure/listedinfo/announcement/c/2005-08-04/600267_2005_z.pdf
106,2005-08-11,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2005-08-11/600267_20050811_1.pdf
107,2005-08-23,海正药业关于通过美国FDA复检的公告,/disclosure/listedinfo/announcement/c/2005-08-23/600267_20050823_1.pdf
108,2005-09-13,海正药业关于遭受台风袭击的公告,/disclosure/listedinfo/announcement/c/2005-09-13/600267_20050913_1.pdf
109,2005-10-25,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-25/600267_2005_3.pdf
110,2005-12-19,海正药业关于召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_1.pdf
111,2005-12-19,海正药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_3.pdf
112,2005-12-19,海正药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_2.pdf
113,2005-12-19,海正药业股权分置改革方案之保荐意见书,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_4.pdf
114,2005-12-19,海正药业股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_5.pdf
115,2005-12-19,海正药业独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_6.pdf
116,2005-12-19,海正药业董事会关于股权分置改革的投票委托征集函,/disclosure/listedinfo/announcement/c/2005-12-19/600267_20051219_7.pdf
117,2005-12-21,海正药业关于控股股东股权转让的提示性公告,/disclosure/listedinfo/announcement/c/2005-12-21/600267_20051221_1.pdf
118,2005-12-23,海正药业关于召开股权分置改革网上投资者交流会的公告,/disclosure/listedinfo/announcement/c/2005-12-23/600267_20051223_1.pdf
119,2005-12-28,海正药业关于股东股权分置改革方案股东沟通协商结果暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2005-12-28/600267_20051228_1.pdf
120,2005-12-28,海正药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2005-12-28/600267_20051228_3.pdf
121,2005-12-28,海正药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2005-12-28/600267_20051228_2.pdf
122,2005-12-28,海正药业股权分置改革方案之补充保荐意见,/disclosure/listedinfo/announcement/c/2005-12-28/600267_20051228_4.pdf
123,2005-12-28,海正药业股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2005-12-28/600267_20051228_5.pdf
124,2005-12-28,海正药业独立董事关于公司股权分置改革事宜之补充意见函,/disclosure/listedinfo/announcement/c/2005-12-28/600267_20051228_6.pdf
125,2005-12-30,海正药业重大事项的进展情况公告,/disclosure/listedinfo/announcement/c/2005-12-30/600267_20051230_1.pdf
126,2006-01-09,海正药业关于召开股权分置改革相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-01-09/600267_20060109_1.pdf
127,2006-01-16,海正药业关于召开股权分置改革相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-01-16/600267_20060116_1.pdf
128,2006-01-16,海正药业关于股权分置改革方案获得国资委批复的公告,/disclosure/listedinfo/announcement/c/2006-01-16/600267_20060116_2.pdf
129,2006-01-20,海正药业股权分置改革相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2006-01-20/600267_20060120_1.pdf
130,2006-01-20,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-01-20/600267_20060120_2.pdf
131,2006-01-21,海正药业股权分置改革相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-01-21/600267_20060121_1.pdf
132,2006-01-21,海正药业高管人员年薪制管理暂行办法,/disclosure/listedinfo/announcement/c/2006-01-21/600267_20060121_2.pdf
133,2006-02-13,海正药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-02-13/600267_20060213_1.pdf
134,2006-02-27,G海正关于控股子公司浙江省医药工业有限公司注册资本变更的公告,/disclosure/listedinfo/announcement/c/2006-02-27/600267_20060227_2.pdf
135,2006-02-27,G海正澄清公告,/disclosure/listedinfo/announcement/c/2006-02-27/600267_20060227_1.pdf
136,2006-03-21,G海正日常关联交易公告,/disclosure/listedinfo/announcement/c/2006-03-21/600267_20060321_3.pdf
137,2006-03-21,G海正年报摘要,/disclosure/listedinfo/announcement/c/2006-03-21/600267_2005_nzy.pdf
138,2006-03-21,G海正年报,/disclosure/listedinfo/announcement/c/2006-03-21/600267_2005_n.pdf
139,2006-03-21,G海正监事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-21/600267_20060321_2.pdf
140,2006-03-21,G海正董事会决议公告暨召开2005年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2006-03-21/600267_20060321_1.pdf
141,2006-03-21,G海正2005年度关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2006-03-21/600267_20060321_4.pdf
142,2006-04-07,G海正关于2005年年度股东大会的补充通知,/disclosure/listedinfo/announcement/c/2006-04-07/600267_20060407_1.pdf
143,2006-04-12,G海正2005年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-04-12/600267_20060412_1.pdf
144,2006-04-13,G海正2005年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-04-13/600267_20060413_1.pdf
145,2006-04-22,G海正公司章程,/disclosure/listedinfo/announcement/c/2006-04-22/600267_20060422_g.pdf
146,2006-04-22,G海正2005年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-04-22/600267_20060422_1.pdf
147,2006-04-22,G海正2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-04-22/600267_20060422_2.pdf
148,2006-04-25,G海正第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-25/600267_2006_1.pdf
149,2006-06-06,G海正2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-06-06/600267_20060606_1.pdf
150,2006-06-09,G海正重大事项公告,/disclosure/listedinfo/announcement/c/2006-06-09/600267_20060609_1.pdf
151,2006-07-15,G海正关于为控股子公司浙江省医药工业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2006-07-15/600267_20060715_2.pdf
152,2006-07-15,G海正董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2006-07-15/600267_20060715_1.pdf
153,2006-07-27,G海正2006年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2006-07-27/600267_20060727_1.pdf
154,2006-07-28,G海正重大事项公告,/disclosure/listedinfo/announcement/c/2006-07-28/600267_20060728_1.pdf
155,2006-08-12,G海正2006年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-08-12/600267_20060812_1.pdf
156,2006-08-12,G海正2006年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-08-12/600267_20060812_2.pdf
157,2006-08-15,G海正董事会决议公告,/disclosure/listedinfo/announcement/c/2006-08-15/600267_20060815_1.pdf
158,2006-08-15,G海正半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-15/600267_2006_zzy.pdf
159,2006-08-15,G海正半年报,/disclosure/listedinfo/announcement/c/2006-08-15/600267_2006_z.pdf
160,2006-10-23,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-10-23/600267_20061023_1.pdf
161,2006-10-23,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-23/600267_2006_3.pdf
162,2006-11-23,海正药业关于控股股东股权划转的公告,/disclosure/listedinfo/announcement/c/2006-11-23/600267_20061123_1.pdf
163,2007-02-13,海正药业有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-02-13/600267_20070213_1.pdf
164,2007-04-03,海正药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2007-04-03/600267_20070403_3.pdf
165,2007-04-03,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2007-04-03/600267_2006_nzy.pdf
166,2007-04-03,海正药业年报,/disclosure/listedinfo/announcement/c/2007-04-03/600267_2006_n.pdf
167,2007-04-03,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-03/600267_20070403_2.pdf
168,2007-04-03,海正药业董事会决议公告暨召开2006年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-04-03/600267_20070403_1.pdf
169,2007-04-03,海正药业2006年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2007-04-03/600267_20070403_4.pdf
170,2007-04-12,海正药业关于第二大股东与浙江中大集团控股有限公司和浙江东方集团控股有限公司合并重组的提示性公告,/disclosure/listedinfo/announcement/c/2007-04-12/600267_20070412_1.pdf
171,2007-04-14,海正药业2006年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-04-14/600267_20070414_1.pdf
172,2007-04-24,海正药业股价异常波动的提示公告,/disclosure/listedinfo/announcement/c/2007-04-24/600267_20070424_1.pdf
173,2007-04-26,海正药业2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-04-26/600267_20070426_1.pdf
174,2007-04-26,海正药业2006年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2007-04-26/600267_20070426_2.pdf
175,2007-04-27,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-27/600267_20070427_2.pdf
176,2007-04-27,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-27/600267_20070427_1.pdf
177,2007-04-27,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-27/600267_2007_1.pdf
178,2007-05-15,海正药业关于股东减持股份的公告,/disclosure/listedinfo/announcement/c/2007-05-15/600267_20070515_1.pdf
179,2007-05-17,海正药业联系方式变更的公告,/disclosure/listedinfo/announcement/c/2007-05-17/600267_20070517_1.pdf
180,2007-06-14,海正药业2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-06-14/600267_20070614_1.pdf
181,2007-06-23,海正药业关于公司治理情况的自查报告及整改计划,/disclosure/listedinfo/announcement/c/2007-06-23/600267_20070623_2.pdf
182,2007-06-23,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-23/600267_20070623_1.pdf
183,2007-06-26,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-06-26/600267_20070626_1.pdf
184,2007-06-30,海正药业关于部分产品出口退税率下调的提示性公告,/disclosure/listedinfo/announcement/c/2007-06-30/600267_20070630_1.pdf
185,2007-07-03,海正药业关于签订重大意向书的提示性公告,/disclosure/listedinfo/announcement/c/2007-07-03/600267_20070703_1.pdf
186,2007-07-04,海正药业关于与雅来公司万古霉素合作进展情况的公告,/disclosure/listedinfo/announcement/c/2007-07-04/600267_20070704_1.pdf
187,2007-07-31,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-07-31/600267_20070731_2.pdf
188,2007-07-31,海正药业关于董事、监事、高管持有公司股份及其变动的规定,/disclosure/listedinfo/announcement/c/2007-07-31/600267_20070731_3.pdf
189,2007-07-31,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-07-31/600267_20070731_1.pdf
190,2007-07-31,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2007-07-31/600267_2007_zzy.pdf
191,2007-07-31,海正药业半年报,/disclosure/listedinfo/announcement/c/2007-07-31/600267_2007_z.pdf
192,2007-08-21,海正药业关于股东减持股份的公告,/disclosure/listedinfo/announcement/c/2007-08-21/600267_20070821_1.pdf
193,2007-09-06,海正药业关于为子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2007-09-06/600267_20070906_2.pdf
194,2007-09-06,海正药业董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2007-09-06/600267_20070906_3.pdf
195,2007-09-06,海正药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-09-06/600267_20070906_1.pdf
196,2007-09-14,海正药业2007年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-09-14/600267_20070914_1.pdf
197,2007-09-18,海正药业关于召开2007年第一次临时股东大会的二次通知,/disclosure/listedinfo/announcement/c/2007-09-18/600267_20070918_1.pdf
198,2007-09-22,海正药业2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-09-22/600267_20070922_1.pdf
199,2007-09-22,海正药业2007年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2007-09-22/600267_20070922_2.pdf
200,2007-09-25,海正药业子公司综合管理制度（2007修订）,/disclosure/listedinfo/announcement/c/2007-09-25/600267_20070925_4.pdf
201,2007-09-25,海正药业关于加强公司治理专项活动的整改报告,/disclosure/listedinfo/announcement/c/2007-09-25/600267_20070925_2.pdf
202,2007-09-25,海正药业关联交易制度（2007修订）,/disclosure/listedinfo/announcement/c/2007-09-25/600267_20070925_3.pdf
203,2007-09-25,海正药业高管人员年薪制管理暂行办法,/disclosure/listedinfo/announcement/c/2007-09-25/600267_20070925_5.pdf
204,2007-09-25,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-09-25/600267_20070925_1.pdf
205,2007-09-27,海正药业业绩预增公告,/disclosure/listedinfo/announcement/c/2007-09-27/600267_20070927_1.pdf
206,2007-10-18,海正药业业绩预增公告,/disclosure/listedinfo/announcement/c/2007-10-18/600267_20071018_2.pdf
207,2007-10-18,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-18/600267_20071018_1.pdf
208,2007-10-18,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-18/600267_2007_3.pdf
209,2007-11-29,海正药业关于与西班牙菲玛公司、富阳兴海投资有限公司签订合资协议的公告,/disclosure/listedinfo/announcement/c/2007-11-29/600267_20071129_1.pdf
210,2007-12-27,海正药业关于股东减持股份的公告,/disclosure/listedinfo/announcement/c/2007-12-27/600267_20071227_1.pdf
211,2007-12-29,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-12-29/600267_20071229_1.pdf
212,2008-01-25,海正药业关于收购浙江弘盛药业有限公司股权的公告,/disclosure/listedinfo/announcement/c/2008-01-25/600267_20080125_1.pdf
213,2008-02-05,海正药业有限售条件的流通股上市流通公告,/disclosure/listedinfo/announcement/c/2008-02-05/600267_20080205_1.pdf
214,2008-02-21,海正药业关于第二大股东与浙江中大集团控股有限公司和浙江东方集团控股有限公司合并重组进展情况的公告,/disclosure/listedinfo/announcement/c/2008-02-21/600267_20080221_1.pdf
215,2008-03-11,海正药业审计委员会对年度财务报告的审议工作规程,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_7.pdf
216,2008-03-11,海正药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_3.pdf
217,2008-03-11,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2008-03-11/600267_2007_nzy.pdf
218,2008-03-11,海正药业年报,/disclosure/listedinfo/announcement/c/2008-03-11/600267_2007_n.pdf
219,2008-03-11,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_2.pdf
220,2008-03-11,海正药业关于为子公司浙江省医药工业有限公司和杭州海正药用植物有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_4.pdf
221,2008-03-11,海正药业独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_6.pdf
222,2008-03-11,海正药业董事会决议公告暨召开2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_1.pdf
223,2008-03-11,海正药业2007年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2008-03-11/600267_20080311_5.pdf
224,2008-03-26,海正药业关于股东减持股份的公告,/disclosure/listedinfo/announcement/c/2008-03-26/600267_20080326_1.pdf
225,2008-04-04,海正药业2007年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-04-04/600267_20080404_1.pdf
226,2008-04-17,海正药业2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-04-17/600267_20080417_1.pdf
227,2008-04-17,海正药业2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-04-17/600267_20080417_2.pdf
228,2008-04-18,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-18/600267_2008_1.pdf
229,2008-04-29,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-04-29/600267_20080429_1.pdf
230,2008-05-14,海正药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2008-05-14/600267_20080514_1.pdf
231,2008-05-31,海正药业2007年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2008-05-31/600267_20080531_1.pdf
232,2008-06-06,海正药业关于第二大股东浙江省国际贸易集团有限公司持有公司股份变更获得国务院国资委批复的公告,/disclosure/listedinfo/announcement/c/2008-06-06/600267_20080606_1.pdf
233,2008-06-06,海正药业股东浙江省国际贸易集团有限公司简式权益变动报告书,/disclosure/listedinfo/announcement/c/2008-06-06/600267_20080606_2.pdf
234,2008-06-11,海正药业关于与Alpharma API Hong Kong Limited签订《合资意向书》的公告,/disclosure/listedinfo/announcement/c/2008-06-11/600267_20080611_1.pdf
235,2008-06-21,海正药业收购资产暨关联交易公告,/disclosure/listedinfo/announcement/c/2008-06-21/600267_20080621_2.pdf
236,2008-06-21,海正药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-06-21/600267_20080621_3.pdf
237,2008-06-21,海正药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-06-21/600267_20080621_1.pdf
238,2008-07-01,海正药业关于召开2008年第一次临时股东大会的二次通知,/disclosure/listedinfo/announcement/c/2008-07-01/600267_20080701_1.pdf
239,2008-07-01,海正药业2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-07-01/600267_20080701_2.pdf
240,2008-07-08,海正药业收购资产暨关联交易公告,/disclosure/listedinfo/announcement/c/2008-07-08/600267_20080708_3.pdf
241,2008-07-08,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-08/600267_20080708_2.pdf
242,2008-07-08,海正药业2008年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2008-07-08/600267_20080708_4.pdf
243,2008-07-08,海正药业2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-07-08/600267_20080708_1.pdf
244,2008-07-17,海正药业关于公司治理专项活动发现问题整改情况的报告,/disclosure/listedinfo/announcement/c/2008-07-17/600267_20080717_2.pdf
245,2008-07-17,海正药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-17/600267_20080717_1.pdf
246,2008-07-22,海正药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2008-07-22/600267_20080722_1.pdf
247,2008-07-30,海正药业关于被授予“创新型企业”的公告,/disclosure/listedinfo/announcement/c/2008-07-30/600267_20080730_1.pdf
248,2008-07-31,海正药业业绩预增公告,/disclosure/listedinfo/announcement/c/2008-07-31/600267_20080731_1.pdf
249,2008-08-09,海正药业关于终止与浙江海正集团有限公司签订的《技术服务合同》的公告,/disclosure/listedinfo/announcement/c/2008-08-09/600267_20080809_1.pdf
250,2008-08-26,海正药业内部控制监督检查实施细则,/disclosure/listedinfo/announcement/c/2008-08-26/600267_20080826_2.pdf
251,2008-08-26,海正药业第四届董事会第十四次会议决议公告暨召开2008年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-08-26/600267_20080826_1.pdf
252,2008-08-26,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-26/600267_2008_zzy.pdf
253,2008-08-26,海正药业半年报,/disclosure/listedinfo/announcement/c/2008-08-26/600267_2008_z.pdf
254,2008-09-04,海正药业2008年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-09-04/600267_20080904_1.pdf
255,2008-09-13,海正药业募集资金管理办法（2008修订）,/disclosure/listedinfo/announcement/c/2008-09-13/600267_20080913_3.pdf
256,2008-09-13,海正药业公司章程（2008修订）,/disclosure/listedinfo/announcement/c/2008-09-13/600267_20080913_g.pdf
257,2008-09-13,海正药业2008年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2008-09-13/600267_20080913_2.pdf
258,2008-09-13,海正药业2008年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-09-13/600267_20080913_1.pdf
259,2008-10-18,海正药业关于被认定为2008年第一批高新技术企业的公告,/disclosure/listedinfo/announcement/c/2008-10-18/600267_20081018_1.pdf
260,2008-10-28,海正药业第四届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2008-10-28/600267_20081028_1.pdf
261,2008-10-28,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-28/600267_2008_3.pdf
262,2008-12-20,海正药业关于为杭州海正药用植物有限公司贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2008-12-20/600267_20081220_2.pdf
263,2008-12-20,海正药业第四届董事会第十六次会议决议公告暨召开2009年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-12-20/600267_20081220_1.pdf
264,2008-12-26,海正药业关于会计师事务所名称变更的公告,/disclosure/listedinfo/announcement/c/2008-12-26/600267_20081226_1.pdf
265,2008-12-26,海正药业2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-12-26/600267_20081226_2.pdf
266,2009-01-06,海正药业2009年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2009-01-06/600267_20090106_2.pdf
267,2009-01-06,海正药业2009年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-01-06/600267_20090106_1.pdf
268,2009-01-09,海正药业第四届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2009-01-09/600267_20090109_1.pdf
269,2009-02-10,海正药业有限售条件的流通股上市流通的公告,/disclosure/listedinfo/announcement/c/2009-02-10/600267_20090210_1.pdf
270,2009-02-18,海正药业关于子公司杭州海正药用植物有限公司获得2008年产业技术进步新增中央预算内资金的公告,/disclosure/listedinfo/announcement/c/2009-02-18/600267_20090218_1.pdf
271,2009-03-03,海正药业审计委员会对年度财务报告的审议工作规程,/disclosure/listedinfo/announcement/c/2009-03-03/600267_20090303_5.pdf
272,2009-03-03,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2009-03-03/600267_2008_nzy.pdf
273,2009-03-03,海正药业年报,/disclosure/listedinfo/announcement/c/2009-03-03/600267_2008_n.pdf
274,2009-03-03,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2009-03-03/600267_20090303_2.pdf
275,2009-03-03,海正药业第四届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-03/600267_20090303_3.pdf
276,2009-03-03,海正药业第四届董事会第十八次会议决议公告暨召开2008年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-03/600267_20090303_1.pdf
277,2009-03-03,海正药业2008年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2009-03-03/600267_20090303_4.pdf
278,2009-03-06,海正药业第四届董事会第十九次会议决议公告暨召开2009年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-03-06/600267_20090306_1.pdf
279,2009-03-20,海正药业2009年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-20/600267_20090320_1.pdf
280,2009-03-20,海正药业2008年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-03-20/600267_20090320_2.pdf
281,2009-03-27,海正药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-03-27/600267_20090327_g.pdf
282,2009-03-27,海正药业2009年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2009-03-27/600267_20090327_4.pdf
283,2009-03-27,海正药业2009年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-27/600267_20090327_2.pdf
284,2009-03-27,海正药业2008年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2009-03-27/600267_20090327_3.pdf
285,2009-03-27,海正药业2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-27/600267_20090327_1.pdf
286,2009-04-21,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-21/600267_2009_1.pdf
287,2009-04-21,海正药业第四届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-21/600267_20090421_1.pdf
288,2009-05-08,海正药业关于与雅赛利香港有限公司签订合资经营合同的公告,/disclosure/listedinfo/announcement/c/2009-05-08/600267_20090508_1.pdf
289,2009-05-13,海正药业2008年利润分配实施公告,/disclosure/listedinfo/announcement/c/2009-05-13/600267_20090513_1.pdf
290,2009-05-15,海正药业澄清公告,/disclosure/listedinfo/announcement/c/2009-05-15/600267_20090515_1.pdf
291,2009-06-02,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2009-06-02/600267_20090602_1.pdf
292,2009-06-26,海正药业第四届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2009-06-26/600267_20090626_1.pdf
293,2009-07-23,海正药业关于子公司杭州海正药用植物有限公司获得项目贴息资金的公告,/disclosure/listedinfo/announcement/c/2009-07-23/600267_20090723_1.pdf
294,2009-08-11,海正药业关于全资子公司杭州海正药用植物有限公司更名的公告,/disclosure/listedinfo/announcement/c/2009-08-11/600267_20090811_1.pdf
295,2009-08-20,海正药业关于公开增发A股股票申请获得审核通过的公告,/disclosure/listedinfo/announcement/c/2009-08-20/600267_20090820_1.pdf
296,2009-08-28,海正药业第四届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-08-28/600267_20090828_1.pdf
297,2009-08-28,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-28/600267_2009_zzy.pdf
298,2009-08-28,海正药业半年报,/disclosure/listedinfo/announcement/c/2009-08-28/600267_2009_z.pdf
299,2009-10-12,海正药业关于中国证监会核准公司增发股票的公告,/disclosure/listedinfo/announcement/c/2009-10-12/600267_20091012_1.pdf
300,2009-10-27,海正药业增发A股网下发行公告,/disclosure/listedinfo/announcement/c/2009-10-27/600267_20091027_2.pdf
301,2009-10-27,海正药业增发A股网上路演公告,/disclosure/listedinfo/announcement/c/2009-10-27/600267_20091027_3.pdf
302,2009-10-27,海正药业增发A股网上发行公告,/disclosure/listedinfo/announcement/c/2009-10-27/600267_20091027_1.pdf
303,2009-10-27,海正药业公开增发A股招股意向书摘要,/disclosure/listedinfo/announcement/c/2009-10-27/600267_20091027_5.pdf
304,2009-10-27,海正药业公开增发A股招股意向书,/disclosure/listedinfo/announcement/c/2009-10-27/600267_20091027_4.pdf
305,2009-10-28,海正药业重大事项公告,/disclosure/listedinfo/announcement/c/2009-10-28/600267_20091028_1.pdf
306,2009-10-29,海正药业增发A股提示性公告,/disclosure/listedinfo/announcement/c/2009-10-29/600267_20091029_1.pdf
307,2009-10-30,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-30/600267_2009_3.pdf
308,2009-11-03,海正药业增发A股网下发行结果及网上中签率公告,/disclosure/listedinfo/announcement/c/2009-11-03/600267_20091103_1.pdf
309,2009-11-04,海正药业增发A股网上资金申购发行摇号中签结果公告,/disclosure/listedinfo/announcement/c/2009-11-04/600267_20091104_1.pdf
310,2009-11-05,海正药业关于签订重大合同的公告,/disclosure/listedinfo/announcement/c/2009-11-05/600267_20091105_1.pdf
311,2009-11-09,海正药业股份变动及增发A股上市公告书,/disclosure/listedinfo/announcement/c/2009-11-09/600267_20091109_1.pdf
312,2009-11-19,海正药业关于以募集资金置换预先已投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2009-11-19/600267_20091119_3.pdf
313,2009-11-19,海正药业关于签署募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2009-11-19/600267_20091119_1.pdf
314,2009-11-19,海正药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-11-19/600267_20091119_g.pdf
315,2009-11-19,海正药业第四届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2009-11-19/600267_20091119_2.pdf
316,2009-11-25,海正药业关于设立境外全资公司进展情况的公告,/disclosure/listedinfo/announcement/c/2009-11-25/600267_20091125_1.pdf
317,2009-11-25,海正药业关于会计师事务所名称变更的公告,/disclosure/listedinfo/announcement/c/2009-11-25/600267_20091125_2.pdf
318,2009-12-01,海正药业关于合资子公司雅赛利（台州）制药有限公司注册成立的公告,/disclosure/listedinfo/announcement/c/2009-12-01/600267_20091201_1.pdf
319,2010-02-02,海正药业第四届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2010-02-02/600267_20100202_1.pdf
320,2010-02-12,海正药业关于投资参股赛金控股有限公司的公告,/disclosure/listedinfo/announcement/c/2010-02-12/600267_20100212_1.pdf
321,2010-03-27,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-27/600267_2009_nzy.pdf
322,2010-03-27,海正药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_9.pdf
323,2010-03-27,海正药业年报,/disclosure/listedinfo/announcement/c/2010-03-27/600267_2009_n.pdf
324,2010-03-27,海正药业内幕信息及信息知情人管理制度,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_7.pdf
325,2010-03-27,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_2.pdf
326,2010-03-27,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_3.pdf
327,2010-03-27,海正药业关于公司高管辞职的公告,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_5.pdf
328,2010-03-27,海正药业关于董事、监事、高管持有公司证券及其变动的规定,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_8.pdf
329,2010-03-27,海正药业第四届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_4.pdf
330,2010-03-27,海正药业第四届董事会第二十六次会议决议公告暨召开2009年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_1.pdf
331,2010-03-27,海正药业2009年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2010-03-27/600267_20100327_6.pdf
332,2010-04-09,海正药业2009年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-09/600267_20100409_1.pdf
333,2010-04-20,海正药业2009年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2010-04-20/600267_20100420_2.pdf
334,2010-04-20,海正药业2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-20/600267_20100420_1.pdf
335,2010-04-21,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-21/600267_2010_1.pdf
336,2010-04-21,海正药业第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-21/600267_20100421_2.pdf
337,2010-04-21,海正药业第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2010-04-21/600267_20100421_1.pdf
338,2010-05-18,海正药业2009年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-05-18/600267_20100518_1.pdf
339,2010-07-30,海正药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2010-07-30/600267_20100730_1.pdf
340,2010-08-03,海正药业子公司综合管理制度,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_7.pdf
341,2010-08-03,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_2.pdf
342,2010-08-03,海正药业关于全资子公司海正生物制药有限公司完成工商登记注册的公告,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_5.pdf
343,2010-08-03,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_3.pdf
344,2010-08-03,海正药业第五届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_4.pdf
345,2010-08-03,海正药业第五届董事会第二次会议决议公告暨召开2010年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_1.pdf
346,2010-08-03,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-03/600267_2010_zzy.pdf
347,2010-08-03,海正药业半年报,/disclosure/listedinfo/announcement/c/2010-08-03/600267_2010_z.pdf
348,2010-08-03,海正药业2010年度非公开发行股票预案,/disclosure/listedinfo/announcement/c/2010-08-03/600267_20100803_6.pdf
349,2010-08-19,海正药业2010年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-08-19/600267_20100819_1.pdf
350,2010-08-26,海正药业关于制剂产品他克莫司胶囊获得欧盟上市批准的公告,/disclosure/listedinfo/announcement/c/2010-08-26/600267_20100826_1.pdf
351,2010-08-26,海正药业关于签订重大研发协议的公告,/disclosure/listedinfo/announcement/c/2010-08-26/600267_20100826_2.pdf
352,2010-08-27,海正药业关于召开2010年第一次临时股东大会的二次通知,/disclosure/listedinfo/announcement/c/2010-08-27/600267_20100827_1.pdf
353,2010-08-31,海正药业关于非公开发行股票事宜获得浙江省国资委批复同意的公告,/disclosure/listedinfo/announcement/c/2010-08-31/600267_20100831_1.pdf
354,2010-09-02,海正药业2010年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2010-09-02/600267_20100902_2.pdf
355,2010-09-02,海正药业2010年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-09-02/600267_20100902_1.pdf
356,2010-10-25,海正药业第五届董事会第三次会议决议公告暨召开2010年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-10-25/600267_20101025_1.pdf
357,2010-10-25,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-25/600267_2010_3.pdf
358,2010-11-05,海正药业2010年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-11-05/600267_20101105_1.pdf
359,2010-11-13,海正药业2010年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2010-11-13/600267_20101113_2.pdf
360,2010-11-13,海正药业2010年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-11-13/600267_20101113_1.pdf
361,2010-11-16,海正药业关于更换保荐代表人的公告,/disclosure/listedinfo/announcement/c/2010-11-16/600267_20101116_1.pdf
362,2010-12-08,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2010-12-08/600267_20101208_2.pdf
363,2010-12-08,海正药业第五届董事会第四次会议决议公告暨召开2010年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2010-12-08/600267_20101208_1.pdf
364,2010-12-15,海正药业2010年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-12-15/600267_20101215_1.pdf
365,2010-12-25,海正药业2010年第三次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2010-12-25/600267_20101225_2.pdf
366,2010-12-25,海正药业2010年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-12-25/600267_20101225_1.pdf
367,2010-12-31,海正药业关于非公开发行A股股票申请获得中国证监会发审会审核通过的公告,/disclosure/listedinfo/announcement/c/2010-12-31/600267_20101231_1.pdf
368,2011-02-12,海正药业关于非公开发行股票获得中国证监会核准的公告,/disclosure/listedinfo/announcement/c/2011-02-12/600267_20110212_1.pdf
369,2011-02-18,海正药业第五届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-18/600267_20110218_1.pdf
370,2011-03-08,海正药业关于多个产品与跨国制药企业的合作进入实施阶段的提示性公告,/disclosure/listedinfo/announcement/c/2011-03-08/600267_20110308_1.pdf
371,2011-03-17,海正药业2010年度非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2011-03-17/600267_20110317_2.pdf
372,2011-03-17,海正药业2010年度非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2011-03-17/600267_20110317_1.pdf
373,2011-03-22,海正药业关于以募集资金置换预先已投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2011-03-22/600267_20110322_2.pdf
374,2011-03-22,海正药业关于签署募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2011-03-22/600267_20110322_4.pdf
375,2011-03-22,海正药业第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-22/600267_20110322_3.pdf
376,2011-03-22,海正药业第五届董事会第六次会议决议公告暨召开2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-03-22/600267_20110322_1.pdf
377,2011-03-22,海正药业2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-03-22/600267_20110322_5.pdf
378,2011-03-29,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2011-03-29/600267_2010_nzy.pdf
379,2011-03-29,海正药业年报,/disclosure/listedinfo/announcement/c/2011-03-29/600267_2010_n.pdf
380,2011-03-29,海正药业内部控制的鉴证报告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_8.pdf
381,2011-03-29,海正药业关于与辉瑞亚太生产有限公司签订供货协议的提示性公告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_6.pdf
382,2011-03-29,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_2.pdf
383,2011-03-29,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_3.pdf
384,2011-03-29,海正药业关联方日常关联交易公告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_4.pdf
385,2011-03-29,海正药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_7.pdf
386,2011-03-29,海正药业第五届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_5.pdf
387,2011-03-29,海正药业第五届董事会第七次会议决议公告暨召开2010年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_1.pdf
388,2011-03-29,海正药业2010年社会责任报告,/disclosure/listedinfo/announcement/c/2011-03-29/600267_20110329_9.pdf
389,2011-04-06,海正药业2011年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2011-04-06/600267_20110406_1.pdf
390,2011-04-07,海正药业公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-04-07/600267_20110407_g.pdf
391,2011-04-07,海正药业2011年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2011-04-07/600267_20110407_2.pdf
392,2011-04-07,海正药业2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-04-07/600267_20110407_1.pdf
393,2011-04-15,海正药业2010年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-04-15/600267_20110415_1.pdf
394,2011-04-25,海正药业与控股股东、实际控制人的信息沟通及披露制度,/disclosure/listedinfo/announcement/c/2011-04-25/600267_20110425_6.pdf
395,2011-04-25,海正药业防范控股股东或实际控制人及关联方资金占用管理制度,/disclosure/listedinfo/announcement/c/2011-04-25/600267_20110425_5.pdf
396,2011-04-25,海正药业董事会秘书管理办法,/disclosure/listedinfo/announcement/c/2011-04-25/600267_20110425_4.pdf
397,2011-04-25,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-25/600267_2011_1.pdf
398,2011-04-25,海正药业第五届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-25/600267_20110425_2.pdf
399,2011-04-25,海正药业2010年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-04-25/600267_20110425_1.pdf
400,2011-04-25,海正药业2010年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2011-04-25/600267_20110425_3.pdf
401,2011-05-06,海正药业2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-05-06/600267_20110506_1.pdf
402,2011-06-03,海正药业关于与辉瑞公司签订《合资意向书》的提示性公告,/disclosure/listedinfo/announcement/c/2011-06-03/600267_20110603_1.pdf
403,2011-06-09,海正药业第五届董事会第九次会议决议公告暨召开2011年度第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-06-09/600267_20110609_1.pdf
404,2011-06-17,海正药业2011年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-06-17/600267_20110617_1.pdf
405,2011-06-25,海正药业2011年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2011-06-25/600267_20110625_2.pdf
406,2011-06-25,海正药业2011年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-06-25/600267_20110625_1.pdf
407,2011-07-08,海正药业2011年半年度业绩预增公告,/disclosure/listedinfo/announcement/c/2011-07-08/600267_20110708_1.pdf
408,2011-07-26,海正药业关于公开发行公司债券申请获得中国证券监督管理委员会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2011-07-26/600267_20110726_1.pdf
409,2011-08-02,海正药业关于以2010年度非公开发行股票闲置募集资金暂时用于补充流动资金的公告,/disclosure/listedinfo/announcement/c/2011-08-02/600267_20110802_3.pdf
410,2011-08-02,海正药业第五届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-02/600267_20110802_2.pdf
411,2011-08-02,海正药业第五届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-02/600267_20110802_1.pdf
412,2011-08-06,海正药业关于公开发行公司债券申请获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2011-08-06/600267_20110806_1.pdf
413,2011-08-20,海正药业关于投资设立海正药业（南通）股份有限公司暨关联交易的公告,/disclosure/listedinfo/announcement/c/2011-08-20/600267_20110820_2.pdf
414,2011-08-20,海正药业第五届董事会第十一次会议决议公告暨召开2011年度第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-08-20/600267_20110820_1.pdf
415,2011-08-23,海正药业公开发行公司债券募集说明书摘要,/disclosure/listedinfo/announcement/c/2011-08-23/600267_20110823_3.pdf
416,2011-08-23,海正药业公开发行公司债券募集说明书,/disclosure/listedinfo/announcement/c/2011-08-23/600267_20110823_2.pdf
417,2011-08-23,海正药业2011年公司债券发行公告,/disclosure/listedinfo/announcement/c/2011-08-23/600267_20110823_1.pdf
418,2011-08-25,海正药业2011年公司债券票面利率公告,/disclosure/listedinfo/announcement/c/2011-08-25/600267_20110825_1.pdf
419,2011-08-30,海正药业金融衍生品交易业务内部控制制度,/disclosure/listedinfo/announcement/c/2011-08-30/600267_20110830_4.pdf
420,2011-08-30,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2011-08-30/600267_20110830_2.pdf
421,2011-08-30,海正药业第五届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-30/600267_20110830_3.pdf
422,2011-08-30,海正药业第五届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-30/600267_20110830_1.pdf
423,2011-08-30,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-30/600267_2011_zzy.pdf
424,2011-08-30,海正药业半年报,/disclosure/listedinfo/announcement/c/2011-08-30/600267_2011_z.pdf
425,2011-08-30,海正药业2011年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-08-30/600267_20110830_5.pdf
426,2011-08-31,海正药业2011年公司债券发行结果公告,/disclosure/listedinfo/announcement/c/2011-08-31/600267_20110831_1.pdf
427,2011-09-06,海正药业2011年第三次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2011-09-06/600267_20110906_2.pdf
428,2011-09-06,海正药业2011年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-09-06/600267_20110906_1.pdf
429,2011-09-15,海正药业关于变更保荐代表人的公告,/disclosure/listedinfo/announcement/c/2011-09-15/600267_20110915_1.pdf
430,2011-09-16,海正药业2011年公司债券上市公告书,/disclosure/listedinfo/announcement/c/2011-09-16/600267_20110916_1.pdf
431,2011-09-27,海正药业关于海正药业南通股份有限公司注册成立及高管变动的公告,/disclosure/listedinfo/announcement/c/2011-09-27/600267_20110927_1.pdf
432,2011-10-18,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2011-10-18/600267_20111018_2.pdf
433,2011-10-18,海正药业高管人员年薪制管理暂行办法,/disclosure/listedinfo/announcement/c/2011-10-18/600267_20111018_4.pdf
434,2011-10-18,海正药业第五届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-18/600267_20111018_3.pdf
435,2011-10-18,海正药业第五届董事会第十三次会议决议公告暨召开2011年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-10-18/600267_20111018_1.pdf
436,2011-10-18,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-18/600267_2011_3.pdf
437,2011-11-04,海正药业2011年第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-11-04/600267_20111104_1.pdf
438,2011-11-12,海正药业2011年第四次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2011-11-12/600267_20111112_2.pdf
439,2011-11-12,海正药业2011年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-11-12/600267_20111112_1.pdf
440,2011-12-02,海正药业关于子公司完成工商登记的公告,/disclosure/listedinfo/announcement/c/2011-12-02/600267_20111202_1.pdf
441,2012-01-05,海正药业提示性公告,/disclosure/listedinfo/announcement/c/2012-01-05/600267_20120105_1.pdf
442,2012-01-11,海正药业关于公司通过高新技术企业复审的公告,/disclosure/listedinfo/announcement/c/2012-01-11/600267_20120111_1.pdf
443,2012-01-20,海正药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2012-01-20/600267_20120120_1.pdf
444,2012-02-20,海正药业关于与辉瑞公司组建合资公司进展情况的提示性公告,/disclosure/listedinfo/announcement/c/2012-02-20/600267_20120220_1.pdf
445,2012-03-03,海正药业第五届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-03/600267_20120303_1.pdf
446,2012-03-13,海正药业关于非公开发行限售股份上市流通提示性公告,/disclosure/listedinfo/announcement/c/2012-03-13/600267_20120313_1.pdf
447,2012-03-27,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2012-03-27/600267_2011_nzy.pdf
448,2012-03-27,海正药业年报,/disclosure/listedinfo/announcement/c/2012-03-27/600267_2011_n.pdf
449,2012-03-27,海正药业内幕信息及信息知情人管理制度,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_13.pdf
450,2012-03-27,海正药业内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_8.pdf
451,2012-03-27,海正药业内部控制的鉴证报告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_9.pdf
452,2012-03-27,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_2.pdf
453,2012-03-27,海正药业关于继续使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_4.pdf
454,2012-03-27,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_3.pdf
455,2012-03-27,海正药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_6.pdf
456,2012-03-27,海正药业独立董事2011年度述职报告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_7.pdf
457,2012-03-27,海正药业董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_12.pdf
458,2012-03-27,海正药业第五届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_5.pdf
459,2012-03-27,海正药业第五届董事会第十五次会议决议公告暨召开2011年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_1.pdf
460,2012-03-27,海正药业财务报告内部控制制度,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_11.pdf
461,2012-03-27,海正药业2011年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_15.pdf
462,2012-03-27,海正药业2011年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_10.pdf
463,2012-03-27,海正药业2011年度募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2012-03-27/600267_20120327_14.pdf
464,2012-03-29,海正药业关于收到台州市环境保护局《限期治理决定书》的公告,/disclosure/listedinfo/announcement/c/2012-03-29/600267_20120329_1.pdf
465,2012-04-20,海正药业2011年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-04-20/600267_20120420_1.pdf
466,2012-04-26,海正药业关于“11海正债”2011年跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2012-04-26/600267_20120426_2.pdf
467,2012-04-26,海正药业2011年年度股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-04-26/600267_20120426_4.pdf
468,2012-04-26,海正药业2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-26/600267_20120426_1.pdf
469,2012-04-26,海正药业2011年公司债券跟踪评级报告,/disclosure/listedinfo/announcement/c/2012-04-26/600267_20120426_3.pdf
470,2012-04-27,海正药业公司债券受托管理事务报告（2011年度）,/disclosure/listedinfo/announcement/c/2012-04-27/600267_20120427_2.pdf
471,2012-04-27,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-27/600267_2012_1.pdf
472,2012-04-27,海正药业第五届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-04-27/600267_20120427_1.pdf
473,2012-05-08,海正药业关于与Celsion公司签订商业供货协议的提示性公告,/disclosure/listedinfo/announcement/c/2012-05-08/600267_20120508_1.pdf
474,2012-05-21,海正药业2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-05-21/600267_20120521_1.pdf
475,2012-05-22,海正药业对外投资公告,/disclosure/listedinfo/announcement/c/2012-05-22/600267_20120522_1.pdf
476,2012-06-14,海正药业关于变更部分募集资金实施主体及实施内容的公告,/disclosure/listedinfo/announcement/c/2012-06-14/600267_20120614_3.pdf
477,2012-06-14,海正药业第五届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-06-14/600267_20120614_2.pdf
478,2012-06-14,海正药业第五届董事会第十七次会议决议公告暨召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-06-14/600267_20120614_1.pdf
479,2012-06-26,海正药业2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-06-26/600267_20120626_1.pdf
480,2012-06-30,海正药业2012年第一次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-06-30/600267_20120630_2.pdf
481,2012-06-30,海正药业2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-06-30/600267_20120630_1.pdf
482,2012-08-04,海正药业第五届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-04/600267_20120804_1.pdf
483,2012-08-08,海正药业关于国家环保部对公司解除挂牌督办的提示性公告,/disclosure/listedinfo/announcement/c/2012-08-08/600267_20120808_1.pdf
484,2012-08-17,海正药业关于11海正债2012年付息公告,/disclosure/listedinfo/announcement/c/2012-08-17/600267_20120817_1.pdf
485,2012-08-28,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2012-08-28/600267_20120828_2.pdf
486,2012-08-28,海正药业关于2012年1-6月募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2012-08-28/600267_20120828_3.pdf
487,2012-08-28,海正药业第五届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-08-28/600267_20120828_4.pdf
488,2012-08-28,海正药业第五届董事会第十九次会议决议公告暨召开2012年度第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-08-28/600267_20120828_1.pdf
489,2012-08-28,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-28/600267_2012_zzy.pdf
490,2012-08-28,海正药业半年报,/disclosure/listedinfo/announcement/c/2012-08-28/600267_2012_z.pdf
491,2012-09-05,海正药业关于子公司获得国家补助资金的提示性公告,/disclosure/listedinfo/announcement/c/2012-09-05/600267_20120905_1.pdf
492,2012-09-13,海正药业关于子公司完成工商登记注册的公告,/disclosure/listedinfo/announcement/c/2012-09-13/600267_20120913_1.pdf
493,2012-09-13,海正药业2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-09-13/600267_20120913_2.pdf
494,2012-09-18,海正药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-09-18/600267_20120918_g.pdf
495,2012-09-18,海正药业2012年第二次临时股东大会之法律意见书,/disclosure/listedinfo/announcement/c/2012-09-18/600267_20120918_2.pdf
496,2012-09-18,海正药业2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-09-18/600267_20120918_1.pdf
497,2012-09-21,海正药业第五届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2012-09-21/600267_20120921_1.pdf
498,2012-09-22,海正药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2012-09-22/600267_20120922_1.pdf
499,2012-10-27,海正药业关于子公司完成工商登记注册的公告,/disclosure/listedinfo/announcement/c/2012-10-27/600267_20121027_1.pdf
500,2012-10-30,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-30/600267_2012_3.pdf
501,2012-11-22,海正药业提示性公告,/disclosure/listedinfo/announcement/c/2012-11-22/600267_20121122_1.pdf
502,2012-12-05,海正药业子公司综合管理制度,/disclosure/listedinfo/announcement/c/2012-12-05/600267_20121205_6.pdf
503,2012-12-05,海正药业关于继续使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2012-12-05/600267_20121205_2.pdf
504,2012-12-05,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2012-12-05/600267_20121205_5.pdf
505,2012-12-05,海正药业第五届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2012-12-05/600267_20121205_3.pdf
506,2012-12-05,海正药业第五届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2012-12-05/600267_20121205_1.pdf
507,2012-12-05,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司继续以闲置募集资金暂时用于补充流动资金的专项意见,/disclosure/listedinfo/announcement/c/2012-12-05/600267_20121205_4.pdf
508,2012-12-29,海正药业第五届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2012-12-28/600267_20121229_1.pdf
509,2013-01-23,海正药业提示性公告,/disclosure/listedinfo/announcement/c/2013-01-22/600267_20130123_1.pdf
510,2013-01-23,海正药业2012年年度业绩预告,/disclosure/listedinfo/announcement/c/2013-01-22/600267_20130123_2.pdf
511,2013-02-01,海正药业提示性公告,/disclosure/listedinfo/announcement/c/2013-01-31/600267_20130201_1.pdf
512,2013-02-07,海正药业关于全资子公司完成工商登记注册的公告,/disclosure/listedinfo/announcement/c/2013-02-06/600267_20130207_1.pdf
513,2013-03-29,海正药业组织结构内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_18.pdf
514,2013-03-29,海正药业审计报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_27.pdf
515,2013-03-29,海正药业企业文化内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_17.pdf
516,2013-03-29,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2013-03-28/600267_2012_nzy.pdf
517,2013-03-29,海正药业年报,/disclosure/listedinfo/announcement/c/2013-03-28/600267_2012_n.pdf
518,2013-03-29,海正药业内部审计内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_16.pdf
519,2013-03-29,海正药业内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_34.pdf
520,2013-03-29,海正药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_28.pdf
521,2013-03-29,海正药业内部控制评价管理办法,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_15.pdf
522,2013-03-29,海正药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_30.pdf
523,2013-03-29,海正药业关于召开2012年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_7.pdf
524,2013-03-29,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_2.pdf
525,2013-03-29,海正药业关于收购子公司浙江省医药工业有限公司15%股权暨关联交易的公告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_1.pdf
526,2013-03-29,海正药业关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_8.pdf
527,2013-03-29,海正药业关于关联方日常关联交易的公告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_9.pdf
528,2013-03-29,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_5.pdf
529,2013-03-29,海正药业风险评估内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_14.pdf
530,2013-03-29,海正药业非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_29.pdf
531,2013-03-29,海正药业发展战略内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_13.pdf
532,2013-03-29,海正药业对外投资内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_12.pdf
533,2013-03-29,海正药业对外捐赠和赞助内控办法,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_11.pdf
534,2013-03-29,海正药业对外担保内控制度,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_10.pdf
535,2013-03-29,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_21.pdf
536,2013-03-29,海正药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_26.pdf
537,2013-03-29,海正药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_25.pdf
538,2013-03-29,海正药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_23.pdf
539,2013-03-29,海正药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_24.pdf
540,2013-03-29,海正药业独立董事关于公司对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_20.pdf
541,2013-03-29,海正药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_33.pdf
542,2013-03-29,海正药业第五届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_4.pdf
543,2013-03-29,海正药业第五届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_3.pdf
544,2013-03-29,海正药业2012年度社会责任报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_32.pdf
545,2013-03-29,海正药业2012年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_22.pdf
546,2013-03-29,海正药业2010年度非公开发行股票持续督导之2012年度报告书,/disclosure/listedinfo/announcement/c/2013-03-28/600267_20130329_31.pdf
547,2013-04-03,海正药业关于召开2012年度网上业绩说明会的公告,/disclosure/listedinfo/announcement/c/2013-04-02/600267_20130403_1.pdf
548,2013-04-18,海正药业2012年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-04-17/600267_20130418_1.pdf
549,2013-04-24,海正药业募集资金管理办法,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_8.pdf
550,2013-04-24,海正药业关于公司章程修订的公告,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_6.pdf
551,2013-04-24,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_10.pdf
552,2013-04-24,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-23/600267_2013_1.pdf
553,2013-04-24,海正药业第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_5.pdf
554,2013-04-24,海正药业第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_4.pdf
555,2013-04-24,海正药业2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_2.pdf
556,2013-04-24,海正药业2012年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-04-23/600267_20130424_9.pdf
557,2013-04-27,海正药业关于“11海正债”2012年跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2013-04-26/600267_20130427_1.pdf
558,2013-04-27,海正药业公司债券受托管理事务报告（2012年度）,/disclosure/listedinfo/announcement/c/2013-04-26/600267_20130427_3.pdf
559,2013-04-27,海正药业2011年公司债券跟踪评级报告,/disclosure/listedinfo/announcement/c/2013-04-26/600267_20130427_2.pdf
560,2013-05-23,海正药业关于六届二次董事会拟审议的关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2013-05-22/600267_20130523_5.pdf
561,2013-05-23,海正药业关于控股股东提供财务资助暨关联交易的公告,/disclosure/listedinfo/announcement/c/2013-05-22/600267_20130523_3.pdf
562,2013-05-23,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-05-22/600267_20130523_4.pdf
563,2013-05-23,海正药业第六届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-05-22/600267_20130523_2.pdf
564,2013-05-23,海正药业第六届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2013-05-22/600267_20130523_1.pdf
565,2013-05-31,海正药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2013-05-30/600267_20130531_1.pdf
566,2013-06-07,海正药业2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-06-06/600267_20130607_2.pdf
567,2013-06-28,海正药业监事辞职公告,/disclosure/listedinfo/announcement/c/2013-06-27/600267_20130628_1.pdf
568,2013-07-09,海正药业年报（修订版）,/disclosure/listedinfo/announcement/c/2013-07-08/600267_2012_n.pdf
569,2013-07-09,海正药业关于召开2013年度第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_6.pdf
570,2013-07-09,海正药业关于增加经营范围暨修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_4.pdf
571,2013-07-09,海正药业关于六届三次董事会拟审议的关联交易事项的事前认可意见,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_9.pdf
572,2013-07-09,海正药业关于控股子公司浙江弘盛药业有限公司及浙江海正动物保健品股份有限公司重组的公告,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_5.pdf
573,2013-07-09,海正药业关于控股股东继续提供财务资助额度暨关联交易的公告,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_3.pdf
574,2013-07-09,海正药业关于2012年年度报告补充公告,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_7.pdf
575,2013-07-09,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_8.pdf
576,2013-07-09,海正药业第六届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_2.pdf
577,2013-07-09,海正药业第六届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2013-07-08/600267_20130709_1.pdf
578,2013-07-12,海正药业关于丁二磺酸腺苷蛋氨酸肠溶片和环丝氨酸胶囊获得药品注册批件的提示性公告,/disclosure/listedinfo/announcement/c/2013-07-11/600267_20130712_1.pdf
579,2013-07-19,海正药业2013年度第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-07-18/600267_20130719_1.pdf
580,2013-07-20,海正药业关于和美国CELSION公司签署谅解备忘录的提示性公告,/disclosure/listedinfo/announcement/c/2013-07-19/600267_20130720_1.pdf
581,2013-07-25,海正药业债券持有人会议规则,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_6.pdf
582,2013-07-25,海正药业前次募集资金使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_5.pdf
583,2013-07-25,海正药业发行可转换公司债券募集资金运用可行性分析报告,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_4.pdf
584,2013-07-25,海正药业第六届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_3.pdf
585,2013-07-25,海正药业第六届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_2.pdf
586,2013-07-25,海正药业2013年度第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_1.pdf
587,2013-07-25,海正药业2013年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-07-24/600267_20130725_7.pdf
588,2013-08-03,海正药业关于转让药品技术的公告,/disclosure/listedinfo/announcement/c/2013-08-02/600267_20130803_1.pdf
589,2013-08-16,海正药业：11海正债2013年付息公告,/disclosure/listedinfo/announcement/c/2013-08-15/600267_20130816_1.pdf
590,2013-08-23,海正药业关于发行可转换公司债券有关事宜获得浙江省国资委批复的公告,/disclosure/listedinfo/announcement/c/2013-08-22/600267_20130823_1.pdf
591,2013-08-27,海正药业关于子公司海正辉瑞制药有限公司利用自有闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_7.pdf
592,2013-08-27,海正药业关于召开2013年度第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_8.pdf
593,2013-08-27,海正药业关于与北京军海等四方签订合作开发框架协议的公告,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_6.pdf
594,2013-08-27,海正药业关于为子公司银行授信提供担保调整的公告,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_5.pdf
595,2013-08-27,海正药业关于2013年上半年募集资金存放和实际使用情况的公告,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_4.pdf
596,2013-08-27,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_10.pdf
597,2013-08-27,海正药业第六届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_3.pdf
598,2013-08-27,海正药业第六届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-08-26/600267_20130827_2.pdf
599,2013-08-27,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-26/600267_2013_zzy.pdf
600,2013-08-27,海正药业半年报,/disclosure/listedinfo/announcement/c/2013-08-26/600267_2013_z.pdf
601,2013-09-05,海正药业关于召开2013年上半年度网上业绩说明会的公告,/disclosure/listedinfo/announcement/c/2013-09-04/600267_20130905_3.pdf
602,2013-09-05,海正药业关于公司2013年度第二次临时股东大会延期召开并增加临时提案的通知,/disclosure/listedinfo/announcement/c/2013-09-04/600267_20130905_2.pdf
603,2013-09-05,海正药业关于本公司及子公司海正辉瑞制药有限公司在上海购置办公用房的公告,/disclosure/listedinfo/announcement/c/2013-09-04/600267_20130905_1.pdf
604,2013-09-11,海正药业关于召开2013年度第二次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2013-09-10/600267_20130911_1.pdf
605,2013-09-11,海正药业2013年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-09-10/600267_20130911_2.pdf
606,2013-09-23,海正药业2013年度第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-09-22/600267_20130923_1.pdf
607,2013-09-23,海正药业2013年度第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-09-22/600267_20130923_2.pdf
608,2013-10-29,海正药业关于召开2013年度第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-10-28/600267_20131029_4.pdf
609,2013-10-29,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2013-10-28/600267_20131029_3.pdf
610,2013-10-29,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-28/600267_2013_3.pdf
611,2013-10-29,海正药业第六届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-10-28/600267_20131029_2.pdf
612,2013-11-08,海正药业2013年度第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-11-07/600267_20131108_1.pdf
613,2013-11-14,海正药业2013年度第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-11-13/600267_20131114_1.pdf
614,2013-11-14,海正药业2013年度第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-11-13/600267_20131114_2.pdf
615,2013-11-16,海正药业提示性公告,/disclosure/listedinfo/announcement/c/2013-11-15/600267_20131116_1.pdf
616,2013-11-30,海正药业信息披露管理办法,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_11.pdf
617,2013-11-30,海正药业前次募集资金使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_9.pdf
618,2013-11-30,海正药业关于召开2013年度第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_6.pdf
619,2013-11-30,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_4.pdf
620,2013-11-30,海正药业关于全资子公司海正药业（杭州）有限公司以固定资产出资及出售资产的公告,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_3.pdf
621,2013-11-30,海正药业关于公司章程修订的公告,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_5.pdf
622,2013-11-30,海正药业关于本次非公开发行股票募集资金运用可行性分析,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_7.pdf
623,2013-11-30,海正药业董事会工作规定,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_10.pdf
624,2013-11-30,海正药业第六届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_2.pdf
625,2013-11-30,海正药业第六届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_1.pdf
626,2013-11-30,海正药业2013年度非公开发行股票预案,/disclosure/listedinfo/announcement/c/2013-11-29/600267_20131130_8.pdf
627,2013-12-03,海正药业关于召开2013年度第四次临时股东大会通知的更正公告,/disclosure/listedinfo/announcement/c/2013-12-02/600267_20131203_1.pdf
628,2013-12-03,海正药业关于召开2013年度第四次临时股东大会的通知（更新）,/disclosure/listedinfo/announcement/c/2013-12-02/600267_20131203_2.pdf
629,2013-12-05,海正药业关于非公开发行股票预案中利润分配政策的补充公告,/disclosure/listedinfo/announcement/c/2013-12-04/600267_20131205_1.pdf
630,2013-12-05,海正药业2013年度非公开发行股票预案（更新）,/disclosure/listedinfo/announcement/c/2013-12-04/600267_20131205_2.pdf
631,2013-12-10,海正药业关于召开2013年度第四次临时股东大会提示性公告,/disclosure/listedinfo/announcement/c/2013-12-09/600267_20131210_2.pdf
632,2013-12-10,海正药业2013年度第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-12-09/600267_20131210_1.pdf
633,2013-12-13,海正药业关于非公开发行股票有关事宜获得浙江省国资委批复的公告,/disclosure/listedinfo/announcement/c/2013-12-12/600267_20131213_2.pdf
634,2013-12-13,海正药业董事会薪酬与考核委员会实施细则,/disclosure/listedinfo/announcement/c/2013-12-12/600267_20131213_4.pdf
635,2013-12-13,海正药业董事会提名委员会实施细则,/disclosure/listedinfo/announcement/c/2013-12-12/600267_20131213_3.pdf
636,2013-12-13,海正药业第六届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2013-12-12/600267_20131213_1.pdf
637,2013-12-18,海正药业2013年度第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-12-17/600267_20131218_1.pdf
638,2013-12-18,海正药业2013年度第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-12-17/600267_20131218_2.pdf
639,2013-12-31,海正药业关于获得国家补助资金的公告,/disclosure/listedinfo/announcement/c/2013-12-30/600267_20131231_1.pdf
640,2014-01-09,海正药业澄清公告,/disclosure/listedinfo/announcement/c/2014-01-08/600267_20140109_1.pdf
641,2014-02-13,海正药业关于相关方承诺履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-12/600267_20140213_1.pdf
642,2014-02-20,海正药业审计委员会对年度财务报告的审议工作规程,/disclosure/listedinfo/announcement/c/2014-02-19/600267_20140220_5.pdf
643,2014-02-20,海正药业董事会专家委员会实施细则,/disclosure/listedinfo/announcement/c/2014-02-19/600267_20140220_4.pdf
644,2014-02-20,海正药业董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2014-02-19/600267_20140220_3.pdf
645,2014-02-20,海正药业董事会工作规定,/disclosure/listedinfo/announcement/c/2014-02-19/600267_20140220_2.pdf
646,2014-02-20,海正药业第六届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-02-19/600267_20140220_1.pdf
647,2014-04-22,海正药业前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_28.pdf
648,2014-04-22,海正药业前次募集资金使用情况的专项报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_9.pdf
649,2014-04-22,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2014-04-21/600267_2013_nzy.pdf
650,2014-04-22,海正药业年报,/disclosure/listedinfo/announcement/c/2014-04-21/600267_2013_n.pdf
651,2014-04-22,海正药业关于子公司海正辉瑞制药有限公司利用自有闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_7.pdf
652,2014-04-22,海正药业关于召开2013年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_10.pdf
653,2014-04-22,海正药业关于修订《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_5.pdf
654,2014-04-22,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_3.pdf
655,2014-04-22,海正药业关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_11.pdf
656,2014-04-22,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_4.pdf
657,2014-04-22,海正药业关于更换财务总监的公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_6.pdf
658,2014-04-22,海正药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_26.pdf
659,2014-04-22,海正药业独立董事关于六届十一次董事会部分事项的意见,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_23.pdf
660,2014-04-22,海正药业独立董事关于公司对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_13.pdf
661,2014-04-22,海正药业独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_16.pdf
662,2014-04-22,海正药业董事会审计委员会2013年度履职情况报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_21.pdf
663,2014-04-22,海正药业第六届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_8.pdf
664,2014-04-22,海正药业第六届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_2.pdf
665,2014-04-22,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司前次募集资金使用情况的核查意见,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_27.pdf
666,2014-04-22,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2013年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_24.pdf
667,2014-04-22,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2010年度非公开发行股票持续督导之2013年度报告书,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_22.pdf
668,2014-04-22,海正药业2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_14.pdf
669,2014-04-22,海正药业2013年度企业社会责任报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_18.pdf
670,2014-04-22,海正药业2013年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_17.pdf
671,2014-04-22,海正药业2013年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_19.pdf
672,2014-04-22,海正药业2013年度募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_25.pdf
673,2014-04-22,海正药业2013年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2014-04-21/600267_20140422_15.pdf
674,2014-04-29,海正药业未来三年（2014年-2016年）股东分红回报规划,/disclosure/listedinfo/announcement/c/2014-04-28/600267_20140429_8.pdf
675,2014-04-29,海正药业关于召开2013年度股东大会的补充通知,/disclosure/listedinfo/announcement/c/2014-04-28/600267_20140429_4.pdf
676,2014-04-29,海正药业关于2013年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2014-04-28/600267_20140429_3.pdf
677,2014-04-29,海正药业独立董事关于六届十二次董事会部分事项的意见,/disclosure/listedinfo/announcement/c/2014-04-28/600267_20140429_7.pdf
678,2014-04-29,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-28/600267_2014_1.pdf
679,2014-04-29,海正药业第六届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-28/600267_20140429_2.pdf
680,2014-05-07,海正药业2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-05-06/600267_20140507_1.pdf
681,2014-05-14,海正药业2013年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-13/600267_20140514_1.pdf
682,2014-05-14,海正药业2013年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-13/600267_20140514_2.pdf
683,2014-05-15,海正药业关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2014-05-14/600267_20140515_1.pdf
684,2014-05-20,海正药业舆情管理制度,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_7.pdf
685,2014-05-20,海正药业投资者关系管理规定,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_8.pdf
686,2014-05-20,海正药业关于最近五年被证券监管部门和交易所采取监管措施及整改情况的公告,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_4.pdf
687,2014-05-20,海正药业关于在上海购置办公用房的进展公告,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_5.pdf
688,2014-05-20,海正药业关于非公开发行股票摊薄即期收益的风险提示性公告,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_3.pdf
689,2014-05-20,海正药业关于非公开发行股票补充信息披露的公告,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_2.pdf
690,2014-05-20,海正药业独立董事关于利润分配政策的独立意见,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_9.pdf
691,2014-05-20,海正药业独立董事辞职公告,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_6.pdf
692,2014-05-20,海正药业第六届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-19/600267_20140520_1.pdf
693,2014-05-22,海正药业关于“11海正债”2013年跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2014-05-21/600267_20140522_1.pdf
694,2014-05-22,海正药业公司债券受托管理事务报告（2013年度）,/disclosure/listedinfo/announcement/c/2014-05-21/600267_20140522_3.pdf
695,2014-05-22,海正药业2011年公司债券跟踪评级报告,/disclosure/listedinfo/announcement/c/2014-05-21/600267_20140522_2.pdf
696,2014-05-29,海正药业关于召开2014年度第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-05-28/600267_20140529_2.pdf
697,2014-05-29,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-05-28/600267_20140529_3.pdf
698,2014-05-29,海正药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2014-05-28/600267_20140529_5.pdf
699,2014-05-29,海正药业独立董事候选人声明,/disclosure/listedinfo/announcement/c/2014-05-28/600267_20140529_4.pdf
700,2014-05-29,海正药业第六届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-28/600267_20140529_1.pdf
701,2014-05-30,海正药业关于控股子公司海正辉瑞制药有限公司富阳生产基地正式投产的提示性公告,/disclosure/listedinfo/announcement/c/2014-05-29/600267_20140530_1.pdf
702,2014-06-10,海正药业2014年度第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-06-09/600267_20140610_1.pdf
703,2014-06-14,海正药业2014年度第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-06-13/600267_20140614_1.pdf
704,2014-06-14,海正药业2014年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-06-13/600267_20140614_2.pdf
705,2014-06-19,海正药业2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-06-18/600267_20140619_2.pdf
706,2014-06-24,海正药业关于子公司海正辉瑞制药有限公司在上海购置办公用房的进展公告,/disclosure/listedinfo/announcement/c/2014-06-23/600267_20140624_1.pdf
707,2014-06-26,海正药业关于实施2013年度利润分配方案后调整非公开发行股票发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2014-06-25/600267_20140626_1.pdf
708,2014-07-03,海正药业关于非公开发行股票申请获得中国证监会发审会审核通过的公告,/disclosure/listedinfo/announcement/c/2014-07-02/600267_20140703_1.pdf
709,2014-07-12,海正药业关于召开2014年度第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_4.pdf
710,2014-07-12,海正药业关于修订《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_3.pdf
711,2014-07-12,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_2.pdf
712,2014-07-12,海正药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_6.pdf
713,2014-07-12,海正药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_7.pdf
714,2014-07-12,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_5.pdf
715,2014-07-12,海正药业第六届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-11/600267_20140712_1.pdf
716,2014-07-24,海正药业关于召开2014年度第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-07-23/600267_20140724_2.pdf
717,2014-07-24,海正药业2014年度第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-07-23/600267_20140724_1.pdf
718,2014-07-30,海正药业2014年度第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-07-29/600267_20140730_1.pdf
719,2014-07-30,海正药业2014年度第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-07-29/600267_20140730_2.pdf
720,2014-08-02,海正药业关于注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白开发进展的公告,/disclosure/listedinfo/announcement/c/2014-08-01/600267_20140802_1.pdf
721,2014-08-02,海正药业关于非公开发行股票获得中国证监会核准批文的公告,/disclosure/listedinfo/announcement/c/2014-08-01/600267_20140802_2.pdf
722,2014-08-19,海正药业：11海正债2014年付息公告,/disclosure/listedinfo/announcement/c/2014-08-18/600267_20140819_1.pdf
723,2014-08-26,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-25/600267_2014_zzy.pdf
724,2014-08-26,海正药业半年报,/disclosure/listedinfo/announcement/c/2014-08-25/600267_2014_z.pdf
725,2014-09-27,海正药业验资报告,/disclosure/listedinfo/announcement/c/2014-09-26/600267_20140927_2.pdf
726,2014-09-27,海正药业：上海市锦天城律师事务所关于浙江海正药业股份有限公司2013年度非公开发行股票发行合规性的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-26/600267_20140927_5.pdf
727,2014-09-27,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2013年度非公开发行股票之发行过程和认购对象合规性的报告,/disclosure/listedinfo/announcement/c/2014-09-26/600267_20140927_4.pdf
728,2014-09-27,海正药业2013年度非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2014-09-26/600267_20140927_3.pdf
729,2014-09-27,海正药业2013年度非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2014-09-26/600267_20140927_1.pdf
730,2014-09-30,海正药业用募集资金置换预先投入的自筹资金公告,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_4.pdf
731,2014-09-30,海正药业关于修订《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_3.pdf
732,2014-09-30,海正药业关于公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_9.pdf
733,2014-09-30,海正药业关于分别签订募集资金专户存储三方和四方监管协议的公告,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_5.pdf
734,2014-09-30,海正药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_7.pdf
735,2014-09-30,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_6.pdf
736,2014-09-30,海正药业第六届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_2.pdf
737,2014-09-30,海正药业第六届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_1.pdf
738,2014-09-30,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司以募集资金置换预先已投入募集资金投资项目自筹资金之核查意见,/disclosure/listedinfo/announcement/c/2014-09-29/600267_20140930_8.pdf
739,2014-10-28,海正药业关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_4.pdf
740,2014-10-28,海正药业关于使用部分闲置募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_5.pdf
741,2014-10-28,海正药业关于取消发行短期融资券的公告,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_7.pdf
742,2014-10-28,海正药业关于会计政策变更和财务信息调整的公告,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_6.pdf
743,2014-10-28,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_8.pdf
744,2014-10-28,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-27/600267_2014_3.pdf
745,2014-10-28,海正药业第六届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_3.pdf
746,2014-10-28,海正药业第六届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_2.pdf
747,2014-10-28,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_10.pdf
748,2014-10-28,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2014-10-27/600267_20141028_11.pdf
749,2014-11-01,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2014-10-31/600267_20141101_1.pdf
750,2014-11-26,海正药业关于注册资本完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2014-11-25/600267_20141126_1.pdf
751,2014-12-13,海正药业关于向控股子公司提供财务资助的公告,/disclosure/listedinfo/announcement/c/2014-12-12/600267_20141213_2.pdf
752,2014-12-13,海正药业关于全资子公司使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2014-12-12/600267_20141213_3.pdf
753,2014-12-13,海正药业独立董事关于六届十九次董事会部分事项的意见,/disclosure/listedinfo/announcement/c/2014-12-12/600267_20141213_4.pdf
754,2014-12-13,海正药业第六届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-12/600267_20141213_1.pdf
755,2014-12-13,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司全资子公司使用部分闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2014-12-12/600267_20141213_5.pdf
756,2014-12-31,海正药业关于控股子公司海正药业南通股份有限公司与海正化工南通股份有限公司发生日常关联交易的公告,/disclosure/listedinfo/announcement/c/2014-12-30/600267_20141231_1.pdf
757,2014-12-31,海正药业关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2014-12-30/600267_20141231_2.pdf
758,2014-12-31,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2014-12-30/600267_20141231_3.pdf
759,2015-01-27,海正药业拟收购股权涉及的云南生物制药有限公司股东全部权益价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_8.pdf
760,2015-01-27,海正药业关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_5.pdf
761,2015-01-27,海正药业关于收购云南生物制药有限公司68%股权的公告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_3.pdf
762,2015-01-27,海正药业关于公司董事辞职的公告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_1.pdf
763,2015-01-27,海正药业公开发行公司债券预案公告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_4.pdf
764,2015-01-27,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_7.pdf
765,2015-01-27,海正药业第六届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_2.pdf
766,2015-01-27,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司持续督导的现场检查报告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150127_6.pdf
767,2015-01-28,海正药业拟收购股权涉及的云南生物制药有限公司股东全部权益价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150128_1.pdf
768,2015-01-28,海正药业关于2015年第一次临时股东大会补充公告,/disclosure/listedinfo/announcement/c/2015-01-27/600267_20150128_2.pdf
769,2015-02-06,海正药业关于召开2015年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-02-05/600267_20150206_1.pdf
770,2015-02-06,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2015-02-05/600267_20150206_2.pdf
771,2015-02-06,海正药业2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-02-05/600267_20150206_3.pdf
772,2015-02-12,海正药业2015年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-02-11/600267_20150212_2.pdf
773,2015-02-12,海正药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-02-11/600267_20150212_1.pdf
774,2015-03-31,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2015-03-30/600267_2014_nzy.pdf
775,2015-03-31,海正药业年报,/disclosure/listedinfo/announcement/c/2015-03-30/600267_2014_n.pdf
776,2015-03-31,海正药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_26.pdf
777,2015-03-31,海正药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_18.pdf
778,2015-03-31,海正药业关于子公司海正辉瑞制药有限公司利用自有闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_5.pdf
779,2015-03-31,海正药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_7.pdf
780,2015-03-31,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_3.pdf
781,2015-03-31,海正药业关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_8.pdf
782,2015-03-31,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_4.pdf
783,2015-03-31,海正药业公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_10.pdf
784,2015-03-31,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_24.pdf
785,2015-03-31,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_23.pdf
786,2015-03-31,海正药业独立董事关于公司对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_12.pdf
787,2015-03-31,海正药业独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_15.pdf
788,2015-03-31,海正药业董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_21.pdf
789,2015-03-31,海正药业第六届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_6.pdf
790,2015-03-31,海正药业第六届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_2.pdf
791,2015-03-31,海正药业：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_14.pdf
792,2015-03-31,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2014年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_20.pdf
793,2015-03-31,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2014年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_25.pdf
794,2015-03-31,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2013年度非公开发行股票持续督导之2014年度报告书,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_22.pdf
795,2015-03-31,海正药业2015年第一季度业绩预减公告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_9.pdf
796,2015-03-31,海正药业2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_13.pdf
797,2015-03-31,海正药业2014年度社会责任报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_17.pdf
798,2015-03-31,海正药业2014年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_19.pdf
799,2015-03-31,海正药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-03-30/600267_20150331_16.pdf
800,2015-04-16,海正药业关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-04-15/600267_20150416_2.pdf
801,2015-04-16,海正药业2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-04-15/600267_20150416_1.pdf
802,2015-04-21,海正药业关于“11海正债”2014年跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2015-04-20/600267_20150421_3.pdf
803,2015-04-21,海正药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-20/600267_2015_1.pdf
804,2015-04-21,海正药业第六届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-20/600267_20150421_2.pdf
805,2015-04-21,海正药业2011年公司债券跟踪评级报告,/disclosure/listedinfo/announcement/c/2015-04-20/600267_20150421_5.pdf
806,2015-04-22,海正药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-04-21/600267_20150422_1.pdf
807,2015-04-22,海正药业2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-04-21/600267_20150422_2.pdf
808,2015-04-23,海正药业关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2015-04-22/600267_20150423_1.pdf
809,2015-04-30,海正药业2011年公司债券受托管理报告（2014年度）,/disclosure/listedinfo/announcement/c/2015-04-29/600267_20150430_1.pdf
810,2015-05-13,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2015-05-12/600267_20150513_1.pdf
811,2015-05-30,海正药业第六届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-29/600267_20150530_1.pdf
812,2015-06-12,海正药业2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-06-11/600267_20150612_1.pdf
813,2015-07-03,海正药业关于与赛诺菲公司签订《非约束性合作备忘录》的公告,/disclosure/listedinfo/announcement/c/2015-07-03/600267_20150703_1.pdf
814,2015-07-07,海正药业关于注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白获得GMP证书的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600267_20150707_2.pdf
815,2015-07-07,海正药业关于与赛诺菲公司签订《非约束性合作备忘录》的补充公告,/disclosure/listedinfo/announcement/c/2015-07-06/600267_20150707_1.pdf
816,2015-07-07,海正药业2015年半年度业绩预减公告,/disclosure/listedinfo/announcement/c/2015-07-06/600267_20150707_3.pdf
817,2015-07-08,海正药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-07/600267_20150708_1.pdf
818,2015-07-11,海正药业关于维护公司股价稳定的公告,/disclosure/listedinfo/announcement/c/2015-07-10/600267_20150711_1.pdf
819,2015-07-15,海正药业股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-14/600267_20150715_1.pdf
820,2015-07-15,海正药业：浙江海正集团有限公司关于浙江海正药业股份有限公司股票交易异常波动征询函的回复,/disclosure/listedinfo/announcement/c/2015-07-14/600267_20150715_2.pdf
821,2015-07-15,海正药业：台州市椒江区国有资产经营有限公司关于浙江海正药业股份有限公司股票交易异常波动征询函的回复,/disclosure/listedinfo/announcement/c/2015-07-14/600267_20150715_3.pdf
822,2015-07-22,海正药业关于向合格投资者公开发行公司债券获得中国证监会核准批复的公告,/disclosure/listedinfo/announcement/c/2015-07-21/600267_20150722_1.pdf
823,2015-08-11,海正药业公开发行2015年公司债券（第一期）募集说明书摘要,/disclosure/listedinfo/announcement/c/2015-08-11/600267_20150811_2.pdf
824,2015-08-11,海正药业公开发行2015年公司债券（第一期）募集说明书,/disclosure/listedinfo/announcement/c/2015-08-11/600267_20150811_1.pdf
825,2015-08-11,海正药业2015年公司债券信用评级报告,/disclosure/listedinfo/announcement/c/2015-08-11/600267_20150811_4.pdf
826,2015-08-11,海正药业2015年公司债券（第一期）发行公告,/disclosure/listedinfo/announcement/c/2015-08-11/600267_20150811_3.pdf
827,2015-08-13,海正药业2015年公司债券（第一期）票面利率公告,/disclosure/listedinfo/announcement/c/2015-08-13/600267_20150813_1.pdf
828,2015-08-14,海正药业关于孙公司获得国家补助资金的公告,/disclosure/listedinfo/announcement/c/2015-08-14/600267_20150814_1.pdf
829,2015-08-18,海正药业关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_6.pdf
830,2015-08-18,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_4.pdf
831,2015-08-18,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_8.pdf
832,2015-08-18,海正药业关于公司2015年上半年募集资金存放和实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_5.pdf
833,2015-08-18,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_10.pdf
834,2015-08-18,海正药业第六届监事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_3.pdf
835,2015-08-18,海正药业第六届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_2.pdf
836,2015-08-18,海正药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-18/600267_2015_zzy.pdf
837,2015-08-18,海正药业半年报,/disclosure/listedinfo/announcement/c/2015-08-18/600267_2015_z.pdf
838,2015-08-18,海正药业：11海正债2015年付息公告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_7.pdf
839,2015-08-18,海正药业2015年公司债券（第一期）发行结果公告,/disclosure/listedinfo/announcement/c/2015-08-18/600267_20150818_20.pdf
840,2015-08-27,海正药业关于召开2015年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-08-27/600267_20150827_1.pdf
841,2015-08-27,海正药业2015年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-08-27/600267_20150827_2.pdf
842,2015-08-28,海正药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2015-08-28/600267_20150828_2.pdf
843,2015-08-28,海正药业关于控股子公司获得财政专项奖励资金的公告,/disclosure/listedinfo/announcement/c/2015-08-28/600267_20150828_1.pdf
844,2015-09-01,海正药业关于浙江云开亚美医药科技股份有限公司增资扩股的公告,/disclosure/listedinfo/announcement/c/2015-09-01/600267_20150901_1.pdf
845,2015-09-01,海正药业：浙江云开亚美医药科技股份有限公司拟进行增资扩股涉及的股东全部权益价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-09-01/600267_20150901_2.pdf
846,2015-09-01,海正药业：浙江云开亚美医药科技股份有限公司2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-09-01/600267_20150901_3.pdf
847,2015-09-03,海正药业2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-09-03/600267_20150903_1.pdf
848,2015-09-03,海正药业2015年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-09-03/600267_20150903_2.pdf
849,2015-09-10,海正药业关于财政部驻宁波市财政监察专员办事处对公司会计信息质量检查及公司整改情况公告,/disclosure/listedinfo/announcement/c/2015-09-10/600267_20150910_1.pdf
850,2015-09-12,海正药业关于 FDA 对台州工厂原料药进口警示的公告,/disclosure/listedinfo/announcement/c/2015-09-12/600267_20150912_2.pdf
851,2015-09-12,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司的专项现场检查报告,/disclosure/listedinfo/announcement/c/2015-09-12/600267_20150912_1.pdf
852,2015-09-22,海正药业关于非公开发行限售股上市流通提示性公告,/disclosure/listedinfo/announcement/c/2015-09-22/600267_20150922_1.pdf
853,2015-09-22,海正药业关于创新药海泽麦布Ⅱ、III期临床试验进展的提示性公告,/disclosure/listedinfo/announcement/c/2015-09-22/600267_20150922_2.pdf
854,2015-09-22,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司限售股份上市流通的核查意见,/disclosure/listedinfo/announcement/c/2015-09-22/600267_20150922_3.pdf
855,2015-09-23,海正药业关于浙江云开亚美医药科技股份有限公司增资扩股挂牌的公告,/disclosure/listedinfo/announcement/c/2015-09-23/600267_20150923_1.pdf
856,2015-10-01,海正药业关于控股子公司获得财政专项补助资金的公告,/disclosure/listedinfo/announcement/c/2015-10-01/600267_20151001_1.pdf
857,2015-10-01,海正药业关于2015年半年报的事后审核意见函的回复公告,/disclosure/listedinfo/announcement/c/2015-10-01/600267_20151001_2.pdf
858,2015-10-01,海正药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2015-10-01/600267_2015_z.pdf
859,2015-10-21,海正药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2015-10-21/600267_20151021_1.pdf
860,2015-10-27,海正药业关于继续使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2015-10-27/600267_20151027_4.pdf
861,2015-10-27,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-10-27/600267_20151027_6.pdf
862,2015-10-27,海正药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-27/600267_2015_3.pdf
863,2015-10-27,海正药业第六届监事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-27/600267_20151027_3.pdf
864,2015-10-27,海正药业第六届董事会第二十七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-10-27/600267_20151027_2.pdf
865,2015-10-27,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2015-10-27/600267_20151027_7.pdf
866,2015-10-30,海正药业关于浙江云开亚美医药科技股份有限公司增资扩股挂牌的进展公告,/disclosure/listedinfo/announcement/c/2015-10-30/600267_20151030_1.pdf
867,2015-11-05,海正药业关于FDA豁免舒巴坦钠进口警示的公告,/disclosure/listedinfo/announcement/c/2015-11-05/600267_20151105_1.pdf
868,2015-11-12,海正药业关于达托霉素申报生产审批进展提示性公告,/disclosure/listedinfo/announcement/c/2015-11-12/600267_20151112_1.pdf
869,2015-11-13,海正药业关于达托霉素申报生产审批进展补充公告,/disclosure/listedinfo/announcement/c/2015-11-13/600267_20151113_1.pdf
870,2015-11-19,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2015-11-19/600267_20151119_1.pdf
871,2015-11-25,海正药业关于特治星供货的进展公告,/disclosure/listedinfo/announcement/c/2015-11-25/600267_20151125_1.pdf
872,2015-11-25,海正药业关于撤回参芪健脑颗粒药品注册的提示性公告,/disclosure/listedinfo/announcement/c/2015-11-25/600267_20151125_2.pdf
873,2015-11-28,海正药业关于召开2015年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_4.pdf
874,2015-11-28,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_3.pdf
875,2015-11-28,海正药业关于使用部分闲置募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_2.pdf
876,2015-11-28,海正药业关于撤回阿莫西林克拉维酸钾片等三个药品注册的提示性公告,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_5.pdf
877,2015-11-28,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_6.pdf
878,2015-11-28,海正药业第六届董事会第二十八次会议决议公告,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_1.pdf
879,2015-11-28,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2015-11-28/600267_20151128_7.pdf
880,2015-12-01,海正药业关于撤回盐酸沙格雷酯片生产注册申请的公告,/disclosure/listedinfo/announcement/c/2015-12-01/600267_20151201_1.pdf
881,2015-12-04,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2015-12-04/600267_20151204_1.pdf
882,2015-12-09,海正药业关于召开2015年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-09/600267_20151209_1.pdf
883,2015-12-09,海正药业2015年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-12-09/600267_20151209_2.pdf
884,2015-12-12,海正药业关于全资子公司归还募集资金的公告,/disclosure/listedinfo/announcement/c/2015-12-12/600267_20151212_1.pdf
885,2015-12-16,海正药业2015年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-12-16/600267_20151216_1.pdf
886,2015-12-16,海正药业2015年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-16/600267_20151216_2.pdf
887,2015-12-25,海正药业关于全资子公司获得《兽药生产许可证》和《兽药GMP证书》的公告,/disclosure/listedinfo/announcement/c/2015-12-25/600267_20151225_1.pdf
888,2015-12-26,海正药业关于全资子公司获得《兽药生产许可证》和《兽药GMP证书》的补充公告,/disclosure/listedinfo/announcement/c/2015-12-26/600267_20151226_1.pdf
889,2015-12-30,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司持续督导的现场检查报告,/disclosure/listedinfo/announcement/c/2015-12-30/600267_20151230_1.pdf
890,2016-01-06,海正药业关于重组抗人表皮生长因子受体人源化单克隆抗体注射液获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-01-06/600267_20160106_1.pdf
891,2016-01-06,海正药业关于撤回奥氮平片等药品生产注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-06/600267_20160106_3.pdf
892,2016-01-06,海正药业关于FDA对台州工厂原料药检查出具警告信的公告,/disclosure/listedinfo/announcement/c/2016-01-06/600267_20160106_2.pdf
893,2016-01-07,海正药业关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-01-07/600267_20160107_1.pdf
894,2016-01-08,海正药业关于通过新版药品GMP认证的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-08/600267_20160108_2.pdf
895,2016-01-08,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-01-08/600267_20160108_1.pdf
896,2016-01-21,海正药业关于重组抗肿瘤坏死因子-a全人源单克隆抗体注射液获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-01-21/600267_20160121_1.pdf
897,2016-01-21,海正药业关于撤回重组抗CD52人源化单克隆抗体注射液临床注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-21/600267_20160121_2.pdf
898,2016-01-22,海正药业关于撤回氨基葡萄糖软骨素片等药品生产注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-22/600267_20160122_1.pdf
899,2016-01-28,海正药业2015年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2016-01-28/600267_20160128_1.pdf
900,2016-02-18,海正药业关于通过新版药品GMP认证的提示性公告,/disclosure/listedinfo/announcement/c/2016-02-18/600267_20160218_2.pdf
901,2016-02-18,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2016-02-18/600267_20160218_1.pdf
902,2016-02-23,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-02-23/600267_20160223_1.pdf
903,2016-03-01,海正药业关于注射用重组抗HER2人源化单克隆抗体获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-03-01/600267_20160301_1.pdf
904,2016-03-14,海正药业2016年公司债券信用评级报告,/disclosure/listedinfo/announcement/c/2016-03-14/600267_20160314_4.pdf
905,2016-03-14,海正药业2016年公司债券发行公告（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-03-14/600267_20160314_2.pdf
906,2016-03-14,海正药业2016年公开发行公司债券募集说明书摘要（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-03-14/600267_20160314_3.pdf
907,2016-03-14,海正药业2016年公开发行公司债券募集说明书（面向合格投资者）,/disclosure/listedinfo/announcement/c/2016-03-14/600267_20160314_1.pdf
908,2016-03-16,海正药业2016年公司债券票面利率公告,/disclosure/listedinfo/announcement/c/2016-03-16/600267_20160316_1.pdf
909,2016-03-18,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-18/600267_20160318_1.pdf
910,2016-03-29,海正药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-03-29/600267_20160329_1.pdf
911,2016-04-01,海正药业关于注射用重组人鼠嵌合抗肿瘤坏死因子-α单克隆抗体获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-04-01/600267_20160401_1.pdf
912,2016-04-01,海正药业2016年公司债券上市公告书,/disclosure/listedinfo/announcement/c/2016-04-01/600267_20160401_8.pdf
913,2016-04-08,海正药业年报摘要,/disclosure/listedinfo/announcement/c/2016-04-08/600267_2015_nzy.pdf
914,2016-04-08,海正药业年报,/disclosure/listedinfo/announcement/c/2016-04-08/600267_2015_n.pdf
915,2016-04-08,海正药业内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_19.pdf
916,2016-04-08,海正药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_18.pdf
917,2016-04-08,海正药业募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_31.pdf
918,2016-04-08,海正药业关于子公司海正辉瑞制药有限公司利用自有闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_6.pdf
919,2016-04-08,海正药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_10.pdf
920,2016-04-08,海正药业关于选举职工代表监事的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_9.pdf
921,2016-04-08,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_3.pdf
922,2016-04-08,海正药业关于控股子公司北京军海药业有限责任公司建设国家应急防控药物工程技术研究中心及产业化基地项目的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_7.pdf
923,2016-04-08,海正药业关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_11.pdf
924,2016-04-08,海正药业关于关联方日常关联交易的公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_4.pdf
925,2016-04-08,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_5.pdf
926,2016-04-08,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_24.pdf
927,2016-04-08,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_29.pdf
928,2016-04-08,海正药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_25.pdf
929,2016-04-08,海正药业独立董事候选人声明（章程）,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_26.pdf
930,2016-04-08,海正药业独立董事候选人声明（吕超）,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_27.pdf
931,2016-04-08,海正药业独立董事候选人声明（陈枢青）,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_28.pdf
932,2016-04-08,海正药业独立董事关于公司对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_12.pdf
933,2016-04-08,海正药业独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_15.pdf
934,2016-04-08,海正药业董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_21.pdf
935,2016-04-08,海正药业第六届监事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_8.pdf
936,2016-04-08,海正药业第六届董事会第二十九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_2.pdf
937,2016-04-08,海正药业：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_14.pdf
938,2016-04-08,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2015年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_30.pdf
939,2016-04-08,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2015年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_20.pdf
940,2016-04-08,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2013年度非公开发行股票持续督导之2015年度报告书,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_23.pdf
941,2016-04-08,海正药业2015年社会责任报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_17.pdf
942,2016-04-08,海正药业2015年度审计报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_13.pdf
943,2016-04-08,海正药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-08/600267_20160408_16.pdf
944,2016-04-23,海正药业关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-23/600267_20160423_1.pdf
945,2016-04-23,海正药业2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-04-23/600267_20160423_2.pdf
946,2016-04-28,海正药业关于枸橼酸托法替布片获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-04-28/600267_20160428_1.pdf
947,2016-04-29,海正药业关于枸橼酸托法替布片获得临床批件的更正公告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_7.pdf
948,2016-04-29,海正药业关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_2.pdf
949,2016-04-29,海正药业关于变更公司投资者联系方式的公告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_6.pdf
950,2016-04-29,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_10.pdf
951,2016-04-29,海正药业第七届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_5.pdf
952,2016-04-29,海正药业第七届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_4.pdf
953,2016-04-29,海正药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_2016_1.pdf
954,2016-04-29,海正药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_1.pdf
955,2016-04-29,海正药业2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-29/600267_20160429_8.pdf
956,2016-05-07,海正药业关于公司债券“11海正债”、“15海正01”及“16海正债”跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2016-05-07/600267_20160507_2.pdf
957,2016-05-07,海正药业关于董事会薪酬与考核委员会主任委员的更正公告,/disclosure/listedinfo/announcement/c/2016-05-07/600267_20160507_1.pdf
958,2016-05-07,海正药业11海正债、15海正01及16海正债跟踪评级报告,/disclosure/listedinfo/announcement/c/2016-05-07/600267_20160507_3.pdf
959,2016-05-10,海正药业关于收到上海证券交易所对公司2015年年度报告事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2016-05-10/600267_20160510_2.pdf
960,2016-05-10,海正药业2011年公司债券受托管理事物报告（2015年度）,/disclosure/listedinfo/announcement/c/2016-05-10/600267_20160510_1.pdf
961,2016-05-17,海正药业2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-05-17/600267_20160517_1.pdf
962,2016-05-18,海正药业关于上海证券交易所对公司2015年年度报告事后审核问询函的回复公告,/disclosure/listedinfo/announcement/c/2016-05-18/600267_20160518_1.pdf
963,2016-05-18,海正药业：关于浙江海正药业股份有限公司2015年年度报告的事后审核问询函中有关财务情况的说明,/disclosure/listedinfo/announcement/c/2016-05-18/600267_20160518_2.pdf
964,2016-05-18,海正药业2015年公司债券（第一期）受托管理事务报告（2015年度）,/disclosure/listedinfo/announcement/c/2016-05-18/600267_20160518_3.pdf
965,2016-05-24,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600267_20160524_1.pdf
966,2016-05-25,海正药业关于重组门冬胰岛素注射液获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-25/600267_20160525_1.pdf
967,2016-05-26,海正药业关于全资子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600267_20160526_2.pdf
968,2016-05-26,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-05-26/600267_20160526_1.pdf
969,2016-06-02,海正药业关于控股子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-06-02/600267_20160602_1.pdf
970,2016-06-09,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2016-06-09/600267_20160609_1.pdf
971,2016-06-14,海正药业关于通过新版药品GMP认证的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-14/600267_20160614_1.pdf
972,2016-06-25,海正药业关于与日本富士胶片株式会社签署抗流感病毒药“Avigan片”相关专利授权合同的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600267_20160625_1.pdf
973,2016-06-25,海正药业关于全资子公司制剂产品厄贝沙坦片获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2016-06-25/600267_20160625_2.pdf
974,2016-06-29,海正药业关于与日本富士胶片株式会社签署抗流感病毒药“Avigan片”相关专利授权合同的补充公告,/disclosure/listedinfo/announcement/c/2016-06-29/600267_20160629_2.pdf
975,2016-06-29,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-06-29/600267_20160629_1.pdf
976,2016-07-01,海正药业关于与日本富士胶片株式会社签署抗流感病毒药“Avigan片”相关专利授权合同的补充公告,/disclosure/listedinfo/announcement/c/2016-07-01/600267_20160701_1.pdf
977,2016-07-19,海正药业关于与美国Nascent生物公司签订技术转让协议的公告,/disclosure/listedinfo/announcement/c/2016-07-19/600267_20160719_1.pdf
978,2016-07-21,海正药业关于与美国Nascent生物公司签订技术转让协议的补充公告,/disclosure/listedinfo/announcement/c/2016-07-21/600267_20160721_1.pdf
979,2016-07-23,海正药业关于控股子公司通过GMP认证的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-23/600267_20160723_1.pdf
980,2016-07-26,海正药业关于与美国Nascent生物公司签订技术转让协议的补充更正公告,/disclosure/listedinfo/announcement/c/2016-07-26/600267_20160726_1.pdf
981,2016-08-10,海正药业“15海正01”2016年付息公告,/disclosure/listedinfo/announcement/c/2016-08-10/600267_20160810_1.pdf
982,2016-08-16,海正药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_9.pdf
983,2016-08-16,海正药业关于修订《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_8.pdf
984,2016-08-16,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_5.pdf
985,2016-08-16,海正药业关于全资子公司海正药业（杭州）有限公司与国开发展基金有限公司合作的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_6.pdf
986,2016-08-16,海正药业关于全资子公司海正药业（杭州）有限公司发行理财直接融资工具的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_7.pdf
987,2016-08-16,海正药业关于公司2016年上半年募集资金存放和实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_4.pdf
988,2016-08-16,海正药业公司章程（2016年8月修订稿）,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_12.pdf
989,2016-08-16,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_11.pdf
990,2016-08-16,海正药业第七届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_3.pdf
991,2016-08-16,海正药业第七届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_20160816_2.pdf
992,2016-08-16,海正药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-16/600267_2016_zzy.pdf
993,2016-08-16,海正药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-16/600267_2016_z.pdf
994,2016-08-17,海正药业关于与 Celsion 公司签订技术转移、生产及商业供货协议的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-17/600267_20160817_2.pdf
995,2016-08-17,海正药业：海正药业（杭州）有限公司拟增资扩股所涉及股东全部权益价值评估报告,/disclosure/listedinfo/announcement/c/2016-08-17/600267_20160817_1.pdf
996,2016-08-18,海正药业11海正债2016年本息兑付及摘牌公告,/disclosure/listedinfo/announcement/c/2016-08-18/600267_20160818_1.pdf
997,2016-08-20,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2016-08-20/600267_20160820_1.pdf
998,2016-08-20,海正药业关于公司和控股子公司获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600267_20160820_2.pdf
999,2016-08-25,海正药业关于收到辉瑞补偿款的公告,/disclosure/listedinfo/announcement/c/2016-08-25/600267_20160825_2.pdf
1000,2016-08-25,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-08-25/600267_20160825_1.pdf
1001,2016-08-27,海正药业关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-27/600267_20160827_2.pdf
1002,2016-08-27,海正药业2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-08-27/600267_20160827_1.pdf
1003,2016-09-01,海正药业关于收到辉瑞补偿款的补充公告,/disclosure/listedinfo/announcement/c/2016-09-01/600267_20160901_1.pdf
1004,2016-09-01,海正药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-01/600267_20160901_2.pdf
1005,2016-09-01,海正药业2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-01/600267_20160901_3.pdf
1006,2016-09-02,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-09-02/600267_20160902_1.pdf
1007,2016-09-09,海正药业关于筹划非公开发行股票停牌的公告,/disclosure/listedinfo/announcement/c/2016-09-09/600267_20160909_1.pdf
1008,2016-09-10,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2016-09-10/600267_20160910_1.pdf
1009,2016-09-20,海正药业关于筹划非公开发行股票事项的进展公告,/disclosure/listedinfo/announcement/c/2016-09-20/600267_20160920_2.pdf
1010,2016-09-20,海正药业第七届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-09-20/600267_20160920_1.pdf
1011,2016-09-22,海正药业关于台州工厂欧盟/WHO联合GMP检查情况的公告,/disclosure/listedinfo/announcement/c/2016-09-22/600267_20160922_1.pdf
1012,2016-09-27,海正药业关于筹划非公开发行股票事项进展暨延期复牌的公告,/disclosure/listedinfo/announcement/c/2016-09-27/600267_20160927_1.pdf
1013,2016-09-27,海正药业：台州市椒江区人民政府关于浙江海正药业股份有限公司非公开发行股票有关事项的说明,/disclosure/listedinfo/announcement/c/2016-09-27/600267_20160927_2.pdf
1014,2016-10-01,海正药业关于监事辞职及补选职工代表监事的公告,/disclosure/listedinfo/announcement/c/2016-10-01/600267_20161001_1.pdf
1015,2016-10-01,海正药业第七届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-01/600267_20161001_2.pdf
1016,2016-10-11,海正药业关于筹划非公开发行股票事项进展暨再次延期复牌的公告,/disclosure/listedinfo/announcement/c/2016-10-11/600267_20161011_1.pdf
1017,2016-10-12,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-10-12/600267_20161012_1.pdf
1018,2016-10-18,海正药业未来三年（2017年-2019年）股东回报规划,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_41.pdf
1019,2016-10-18,海正药业实际控制人关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_38.pdf
1020,2016-10-18,海正药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_33.pdf
1021,2016-10-18,海正药业控股股东关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_39.pdf
1022,2016-10-18,海正药业监事会关于公司第一期员工持股计划的审核意见,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_31.pdf
1023,2016-10-18,海正药业关于公司与特定对象签署附条件生效的股份认购协议的公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_45.pdf
1024,2016-10-18,海正药业关于公司非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_44.pdf
1025,2016-10-18,海正药业关于非公开发行股票摊薄即期回报对公司主要财务指标的影响及采取措施的公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_46.pdf
1026,2016-10-18,海正药业关于筹划非公开发行股票事项进展暨复牌的提示性公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_50.pdf
1027,2016-10-18,海正药业独立董事关于公司非公开发行暨关联交易事前认可意见,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_49.pdf
1028,2016-10-18,海正药业独立董事对第七届董事会第五次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_30.pdf
1029,2016-10-18,海正药业董事、高级管理人员关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_40.pdf
1030,2016-10-18,海正药业第一期员工持股计划管理办法,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_37.pdf
1031,2016-10-18,海正药业第一期员工持股计划（草案）摘要（认购非公开发行股票方式）,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_36.pdf
1032,2016-10-18,海正药业第一期员工持股计划（草案）（认购非公开发行股票方式）,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_35.pdf
1033,2016-10-18,海正药业第三届职工代表大会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_47.pdf
1034,2016-10-18,海正药业第七届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_43.pdf
1035,2016-10-18,海正药业第七届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_42.pdf
1036,2016-10-18,海正药业：前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_34.pdf
1037,2016-10-18,海正药业2016年度非公开发行股票募集资金使用的可行性分析报告,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_32.pdf
1038,2016-10-18,海正药业2016年度非公开发行A股股票预案,/disclosure/listedinfo/announcement/c/2016-10-18/600267_20161018_48.pdf
1039,2016-10-20,海正药业关于全资子公司制剂产品厄贝沙坦氢氯噻嗪片获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2016-10-20/600267_20161020_1.pdf
1040,2016-10-21,海正药业关于归还募集资金的公告,/disclosure/listedinfo/announcement/c/2016-10-21/600267_20161021_1.pdf
1041,2016-10-29,海正药业第七届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-29/600267_20161029_2.pdf
1042,2016-10-29,海正药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-29/600267_2016_3.pdf
1043,2016-11-02,海正药业关于欧盟允许公司30个品种继续出口欧洲市场的公告,/disclosure/listedinfo/announcement/c/2016-11-02/600267_20161102_1.pdf
1044,2016-11-04,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-11-04/600267_20161104_1.pdf
1045,2016-11-12,海正药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2016-11-12/600267_20161112_1.pdf
1046,2016-11-17,海正药业停牌公告,/disclosure/listedinfo/announcement/c/2016-11-17/600267_20161117_2.pdf
1047,2016-11-17,海正药业关于收到上海证券交易所对公司有关媒体报道等事项的问询函的公告,/disclosure/listedinfo/announcement/c/2016-11-17/600267_20161117_1.pdf
1048,2016-11-19,海正药业关于重组抗白介素-6受体人源化单克隆抗体注射液获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_4.pdf
1049,2016-11-19,海正药业关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_3.pdf
1050,2016-11-19,海正药业关于上海证券交易所对公司有关媒体报道等事项的问询函的回复公告,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_5.pdf
1051,2016-11-19,海正药业股票复牌公告,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_10.pdf
1052,2016-11-19,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_9.pdf
1053,2016-11-19,海正药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_6.pdf
1054,2016-11-19,海正药业独立董事候选人声明（武鑫）,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_8.pdf
1055,2016-11-19,海正药业独立董事候选人声明（孟晓俊）,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_7.pdf
1056,2016-11-19,海正药业第七届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_2.pdf
1057,2016-11-19,海正药业第七届董事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-19/600267_20161119_1.pdf
1058,2016-11-22,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-11-22/600267_20161122_1.pdf
1059,2016-11-30,海正药业2016年度第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-11-30/600267_20161130_1.pdf
1060,2016-12-01,海正药业关于召开2016年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-01/600267_20161201_1.pdf
1061,2016-12-06,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-12-06/600267_20161206_1.pdf
1062,2016-12-07,海正药业2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-12-07/600267_20161207_1.pdf
1063,2016-12-07,海正药业2016年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-12-07/600267_20161207_2.pdf
1064,2016-12-16,海正药业关于聘任公司董事会秘书的公告,/disclosure/listedinfo/announcement/c/2016-12-16/600267_20161216_4.pdf
1065,2016-12-16,海正药业关于更换财务总监的公告,/disclosure/listedinfo/announcement/c/2016-12-16/600267_20161216_3.pdf
1066,2016-12-16,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-12-16/600267_20161216_5.pdf
1067,2016-12-16,海正药业第七届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-16/600267_20161216_2.pdf
1068,2016-12-16,海正药业第七届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-16/600267_20161216_1.pdf
1069,2016-12-24,海正药业关于重组抗RANKL全人源单克隆抗体注射液获得临床批件的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600267_20161224_1.pdf
1070,2016-12-24,海正药业关于海泽麦布阿托伐他汀钙片获得临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-12-24/600267_20161224_2.pdf
1071,2016-12-31,海正药业关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-12-31/600267_20161231_4.pdf
1072,2016-12-31,海正药业关于为全资子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2016-12-31/600267_20161231_3.pdf
1073,2016-12-31,海正药业关于使用部分闲置募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2016-12-31/600267_20161231_2.pdf
1074,2016-12-31,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-12-31/600267_20161231_5.pdf
1075,2016-12-31,海正药业第七届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-31/600267_20161231_1.pdf
1076,2016-12-31,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2016-12-31/600267_20161231_6.pdf
1077,2017-01-13,海正药业关于召开2017年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-01-13/600267_20170113_2.pdf
1078,2017-01-13,海正药业2017年度第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-01-13/600267_20170113_1.pdf
1079,2017-01-14,海正药业第七届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-01-14/600267_20170114_1.pdf
1080,2017-01-18,海正药业2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-01-18/600267_20170118_1.pdf
1081,2017-01-18,海正药业2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-01-18/600267_20170118_2.pdf
1082,2017-01-21,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-01-21/600267_20170121_1.pdf
1083,2017-01-25,海正药业关于甘精胰岛素、甘精胰岛素注射液及注射用结核病变态反应原RP22获得临床批件的公告,/disclosure/listedinfo/announcement/c/2017-01-25/600267_20170125_2.pdf
1084,2017-01-25,海正药业2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-25/600267_20170125_1.pdf
1085,2017-02-10,海正药业关于收到浙江证监局《行政监管措施决定书》的公告,/disclosure/listedinfo/announcement/c/2017-02-10/600267_20170210_1.pdf
1086,2017-02-22,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-02-22/600267_20170222_1.pdf
1087,2017-02-24,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-02-24/600267_20170224_1.pdf
1088,2017-02-24,海正药业关于公司及子公司产品列入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-02-24/600267_20170224_2.pdf
1089,2017-02-25,海正药业关于公司及子公司产品列入国家医保目录的补充公告,/disclosure/listedinfo/announcement/c/2017-02-25/600267_20170225_1.pdf
1090,2017-03-09,海正药业“16海正债”2017年付息公告,/disclosure/listedinfo/announcement/c/2017-03-09/600267_20170309_1.pdf
1091,2017-03-15,海正药业关于通过新版药品GMP认证的提示性公告,/disclosure/listedinfo/announcement/c/2017-03-15/600267_20170315_1.pdf
1092,2017-03-16,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-03-16/600267_20170316_1.pdf
1093,2017-03-29,海正药业关于收到上海证券交易所对公司业绩预告更正事项的问询函的公告,/disclosure/listedinfo/announcement/c/2017-03-29/600267_20170329_2.pdf
1094,2017-03-29,海正药业2016年年度业绩预告更正公告,/disclosure/listedinfo/announcement/c/2017-03-29/600267_20170329_1.pdf
1095,2017-03-31,海正药业关于制剂产品多奈哌齐片获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2017-03-31/600267_20170331_4.pdf
1096,2017-03-31,海正药业关于与三家公司签署四个产品销售权协议的公告,/disclosure/listedinfo/announcement/c/2017-03-31/600267_20170331_2.pdf
1097,2017-03-31,海正药业关于上海证券交易所对公司业绩预告更正事项的问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-03-31/600267_20170331_3.pdf
1098,2017-03-31,海正药业关于监事短线交易的公告,/disclosure/listedinfo/announcement/c/2017-03-31/600267_20170331_1.pdf
1099,2017-04-05,海正药业关于延期披露定期报告的公告,/disclosure/listedinfo/announcement/c/2017-04-05/600267_20170405_1.pdf
1100,2017-04-07,海正药业关于收到上海证券交易所对公司签署产品销售权协议事项的问询函的公告,/disclosure/listedinfo/announcement/c/2017-04-07/600267_20170407_1.pdf
1101,2017-04-10,海正药业关于入选浙江省第一批国有控股混合所有制企业员工持股试点的公告,/disclosure/listedinfo/announcement/c/2017-04-10/600267_20170410_1.pdf
1102,2017-04-11,海正药业关于延期披露上海证券交易所问询函回复的公告,/disclosure/listedinfo/announcement/c/2017-04-11/600267_20170411_1.pdf
1103,2017-04-15,海正药业关于上海证券交易所对公司签署产品销售权协议事项的问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-04-15/600267_20170415_1.pdf
1104,2017-04-18,海正药业关于子公司海正辉瑞制药有限公司利用自有闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_6.pdf
1105,2017-04-18,海正药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_12.pdf
1106,2017-04-18,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_3.pdf
1107,2017-04-18,海正药业关于特治星产品供货情况的提示性公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_14.pdf
1108,2017-04-18,海正药业关于使用部分闲置募集资金暂时补充流动资金的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_9.pdf
1109,2017-04-18,海正药业关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_13.pdf
1110,2017-04-18,海正药业关于计提商誉减值准备的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_7.pdf
1111,2017-04-18,海正药业关于关联方日常关联交易的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_4.pdf
1112,2017-04-18,海正药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_5.pdf
1113,2017-04-18,海正药业关于公司监事辞职及补选监事的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_11.pdf
1114,2017-04-18,海正药业关于调整非公开发行募集资金投资项目建设进度的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_8.pdf
1115,2017-04-18,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_28.pdf
1116,2017-04-18,海正药业独立董事关于公司对外担保情况的专项说明和独立意见,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_16.pdf
1117,2017-04-18,海正药业独立董事2016年度述职报告（章程）,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_27.pdf
1118,2017-04-18,海正药业独立董事2016年度述职报告（孟晓俊）,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_25.pdf
1119,2017-04-18,海正药业独立董事2016年度述职报告（吕超）,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_26.pdf
1120,2017-04-18,海正药业独立董事2016年度述职报告（陈枢青）,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_19.pdf
1121,2017-04-18,海正药业董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_24.pdf
1122,2017-04-18,海正药业第七届监事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_10.pdf
1123,2017-04-18,海正药业第七届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_2.pdf
1124,2017-04-18,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_32.pdf
1125,2017-04-18,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司调整募集资金投资项目建设进度的核查意见,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_31.pdf
1126,2017-04-18,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2016年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_29.pdf
1127,2017-04-18,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司2016年度募集资金存放与实际使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_23.pdf
1128,2017-04-18,海正药业：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_17.pdf
1129,2017-04-18,海正药业：2016年度内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_22.pdf
1130,2017-04-18,海正药业：2016年度募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_21.pdf
1131,2017-04-18,海正药业：2016年度募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_30.pdf
1132,2017-04-18,海正药业：2016年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_18.pdf
1133,2017-04-18,海正药业2016年社会责任报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_20170418_20.pdf
1134,2017-04-18,海正药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-18/600267_2016_nzy.pdf
1135,2017-04-18,海正药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-18/600267_2016_n.pdf
1136,2017-04-19,海正药业关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-04-19/600267_20170419_1.pdf
1137,2017-04-19,海正药业关于为子公司银行贷款提供担保的补充公告,/disclosure/listedinfo/announcement/c/2017-04-19/600267_20170419_2.pdf
1138,2017-04-19,海正药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-19/600267_20170419_3.pdf
1139,2017-04-25,海正药业关于收到浙江证监局《行政监管措施决定书》的公告,/disclosure/listedinfo/announcement/c/2017-04-25/600267_20170425_1.pdf
1140,2017-04-26,海正药业关于收到上海证券交易所对公司2016年年度报告的事后审核问询函的公告,/disclosure/listedinfo/announcement/c/2017-04-26/600267_20170426_2.pdf
1141,2017-04-26,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-04-26/600267_20170426_1.pdf
1142,2017-04-28,海正药业第七届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-28/600267_20170428_3.pdf
1143,2017-04-28,海正药业第七届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-28/600267_20170428_2.pdf
1144,2017-04-28,海正药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-28/600267_2017_1.pdf
1145,2017-04-29,海正药业关于收到上海证券交易所对公司2017年第一季度报告相关事项的问询函的公告,/disclosure/listedinfo/announcement/c/2017-04-29/600267_20170429_1.pdf
1146,2017-05-04,海正药业关于召开2016年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-04/600267_20170504_2.pdf
1147,2017-05-04,海正药业2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-04/600267_20170504_1.pdf
1148,2017-05-05,海正药业关于延期回复上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-05-05/600267_20170505_3.pdf
1149,2017-05-09,海正药业关于上海证券交易所对公司2017年第一季度报告相关事项的问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-05-09/600267_20170509_3.pdf
1150,2017-05-09,海正药业关于上海证券交易所对公司2016年年度报告事后审核问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-05-09/600267_20170509_1.pdf
1151,2017-05-09,海正药业关于补充披露公司及控股子公司2016年度获得政府补助的公告,/disclosure/listedinfo/announcement/c/2017-05-09/600267_20170509_4.pdf
1152,2017-05-09,海正药业：天健会计师事务所关于浙江海正药业股份有限公司2016年年度报告的事后审核问询函中有关财务情况的说明,/disclosure/listedinfo/announcement/c/2017-05-09/600267_20170509_2.pdf
1153,2017-05-10,海正药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-05-10/600267_20170510_1.pdf
1154,2017-05-10,海正药业2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-05-10/600267_20170510_2.pdf
1155,2017-05-11,海正药业关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2017-05-11/600267_20170511_3.pdf
1156,2017-05-11,海正药业关于2016年年报全文修订的说明,/disclosure/listedinfo/announcement/c/2017-05-11/600267_20170511_1.pdf
1157,2017-05-11,海正药业2016年年度报告（修订稿）,/disclosure/listedinfo/announcement/c/2017-05-11/600267_2016_n.pdf
1158,2017-05-19,海正药业关于公司债券“15海正01”及“16海正债”跟踪评级结果的公告,/disclosure/listedinfo/announcement/c/2017-05-19/600267_20170519_1.pdf
1159,2017-05-19,海正药业15海正01及16海正债跟踪评级报告,/disclosure/listedinfo/announcement/c/2017-05-19/600267_20170519_2.pdf
1160,2017-05-24,海正药业关于FDA解除对台州工厂人用原料药进口禁令的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-24/600267_20170524_1.pdf
1161,2017-05-25,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-05-25/600267_20170525_1.pdf
1162,2017-05-27,海正药业关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-27/600267_20170527_4.pdf
1163,2017-05-27,海正药业关于更换公司董事的公告,/disclosure/listedinfo/announcement/c/2017-05-27/600267_20170527_3.pdf
1164,2017-05-27,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2017-05-27/600267_20170527_2.pdf
1165,2017-05-27,海正药业第七届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-27/600267_20170527_1.pdf
1166,2017-06-05,海正药业关于美国FDA关闭公司台州工厂警告信及解除兽用原料药进口禁令的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-05/600267_20170605_1.pdf
1167,2017-06-08,海正药业关于召开2017年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-06-08/600267_20170608_1.pdf
1168,2017-06-08,海正药业2017年度第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-06-08/600267_20170608_2.pdf
1169,2017-06-14,海正药业2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-14/600267_20170614_1.pdf
1170,2017-06-14,海正药业2017年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-14/600267_20170614_2.pdf
1171,2017-06-14,海正药业15海正01及16海正债受托管理事务报告（2016年度）,/disclosure/listedinfo/announcement/c/2017-06-14/600267_20170614_3.pdf
1172,2017-06-21,海正药业第七届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-06-21/600267_20170621_1.pdf
1173,2017-06-26,海正药业关于重组人血白蛋白获得临床批件的公告,/disclosure/listedinfo/announcement/c/2017-06-26/600267_20170626_1.pdf
1174,2017-06-27,海正药业关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-06-27/600267_20170627_1.pdf
1175,2017-06-28,海正药业关于孙公司获得政府补助资金的公告,/disclosure/listedinfo/announcement/c/2017-06-28/600267_20170628_1.pdf
1176,2017-06-28,海正药业关于控股子公司获得药品GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-06-28/600267_20170628_2.pdf
1177,2017-06-29,海正药业关于孙公司获得政府补助资金的补充公告,/disclosure/listedinfo/announcement/c/2017-06-29/600267_20170629_1.pdf
1178,2017-06-30,海正药业2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-06-30/600267_20170630_1.pdf
1179,2017-07-25,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-07-25/600267_20170725_1.pdf
1180,2017-07-25,海正药业关于媒体报道之特治星供货情况的说明公告,/disclosure/listedinfo/announcement/c/2017-07-25/600267_20170725_2.pdf
1181,2017-08-03,海正药业关于控股子公司获得中央财政专项补助资金的公告,/disclosure/listedinfo/announcement/c/2017-08-03/600267_20170803_1.pdf
1182,2017-08-07,海正药业2015年公开发行公司债券（第一期）2017年付息公告,/disclosure/listedinfo/announcement/c/2017-08-07/600267_20170807_1.pdf
1183,2017-08-10,海正药业第七届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-10/600267_20170810_1.pdf
1184,2017-08-17,海正药业关于子公司获得中央财政专项补助资金的进展公告,/disclosure/listedinfo/announcement/c/2017-08-17/600267_20170817_1.pdf
1185,2017-08-19,海正药业关于子公司获得中央财政专项补助资金进展的补充公告,/disclosure/listedinfo/announcement/c/2017-08-19/600267_20170819_1.pdf
1186,2017-08-22,海正药业关于召开2017年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_16.pdf
1187,2017-08-22,海正药业关于为子公司银行贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_9.pdf
1188,2017-08-22,海正药业关于全资子公司海正生物制药有限公司增资扩股的公告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_10.pdf
1189,2017-08-22,海正药业关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_8.pdf
1190,2017-08-22,海正药业关于公司2017年上半年募集资金存放和实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_7.pdf
1191,2017-08-22,海正药业独立董事关于七届十六次董事会部分事项的意见,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_4.pdf
1192,2017-08-22,海正药业第七届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_15.pdf
1193,2017-08-22,海正药业第七届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_3.pdf
1194,2017-08-22,海正药业：拟增资项目涉及的海正生物制药有限公司股东全部权益价值资产评估报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_13.pdf
1195,2017-08-22,海正药业：拟增资海正生物制药有限公司项目涉及的实物资产及无形资产资产评估报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_14.pdf
1196,2017-08-22,海正药业：拟以无形资产出资新设公司项目涉及其拥有的无形资产资产评估报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_6.pdf
1197,2017-08-22,海正药业：海正药业（杭州）有限公司拟增资海正生物制药有限公司项目涉及的实物资产及无形资产资产评估报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_11.pdf
1198,2017-08-22,海正药业：海正药业（杭州）有限公司拟出资设立公司项目涉及的实物资产及土地使用权资产评估报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_5.pdf
1199,2017-08-22,海正药业：海正生物制药有限公司拟股权收购项目涉及的上海百盈医药科技有限公司股东全部权益资产评估报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_20170822_12.pdf
1200,2017-08-22,海正药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-22/600267_2017_zzy.pdf
1201,2017-08-22,海正药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-22/600267_2017_z.pdf
1202,2017-08-25,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-08-25/600267_20170825_1.pdf
1203,2017-08-31,海正药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_14.pdf
1204,2017-08-31,海正药业监事会关于公司第一期员工持股计划的审核意见,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_5.pdf
1205,2017-08-31,海正药业关于近五年被监管部门采取监管措施或处罚及整改情况的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_11.pdf
1206,2017-08-31,海正药业关于公司与特定对象签署附条件生效的股份认购协议的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_7.pdf
1207,2017-08-31,海正药业关于公司非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_6.pdf
1208,2017-08-31,海正药业关于非公开发行股票摊薄即期回报对公司主要财务指标的影响及采取措施的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_8.pdf
1209,2017-08-31,海正药业关于非公开发行A股股票预案修订情况说明的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_10.pdf
1210,2017-08-31,海正药业独立董事关于公司非公开发行暨关联交易事前认可意见,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_2.pdf
1211,2017-08-31,海正药业独立董事对第七届董事会第十七次会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_3.pdf
1212,2017-08-31,海正药业董事、高级管理人员关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_16.pdf
1213,2017-08-31,海正药业第一期员工持股计划管理办法（修订稿）,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_21.pdf
1214,2017-08-31,海正药业第一期员工持股计划（草案）（修订稿）（认购非公开发行股票方式）,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_19.pdf
1215,2017-08-31,海正药业第一期员工持股计划（草案）（修订版）摘要（认购非公开发行股票方式）,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_20.pdf
1216,2017-08-31,海正药业第四届职工代表大会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_9.pdf
1217,2017-08-31,海正药业第七届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_4.pdf
1218,2017-08-31,海正药业第七届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_1.pdf
1219,2017-08-31,海正药业：实际控制人关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_17.pdf
1220,2017-08-31,海正药业：前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_15.pdf
1221,2017-08-31,海正药业：控股股东关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_18.pdf
1222,2017-08-31,海正药业2016年度非公开发行股票募集资金使用的可行性分析报告（修订稿）,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_13.pdf
1223,2017-08-31,海正药业2016年度非公开发行A股股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2017-08-31/600267_20170831_12.pdf
1224,2017-09-01,海正药业关于召开2017年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-09-01/600267_20170901_2.pdf
1225,2017-09-01,海正药业2017年度第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-09-01/600267_20170901_1.pdf
1226,2017-09-07,海正药业2017年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-09-07/600267_20170907_1.pdf
1227,2017-09-07,海正药业2017年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-09-07/600267_20170907_2.pdf
1228,2017-09-09,海正药业关于孙公司制剂产品二甲双胍缓释片获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2017-09-09/600267_20170909_1.pdf
1229,2017-09-26,海正药业关于全资子公司吡喹酮原料药通过WHO的PQ认证的公告,/disclosure/listedinfo/announcement/c/2017-09-26/600267_20170926_1.pdf
1230,2017-09-27,海正药业第七届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2017-09-27/600267_20170927_1.pdf
1231,2017-09-30,海正药业关于注销部分募集资金专项账户的公告,/disclosure/listedinfo/announcement/c/2017-09-30/600267_20170930_1.pdf
1232,2017-10-11,海正药业关于获得澳大利亚TGA-GMP证书的公告,/disclosure/listedinfo/announcement/c/2017-10-11/600267_20171011_1.pdf
1233,2017-10-13,海正药业关于获得澳大利亚TGA-GMP证书的补充公告,/disclosure/listedinfo/announcement/c/2017-10-13/600267_20171013_1.pdf
1234,2017-10-18,海正药业关于更换公司董事会秘书的公告,/disclosure/listedinfo/announcement/c/2017-10-18/600267_20171018_4.pdf
1235,2017-10-18,海正药业关于更换财务总监的公告,/disclosure/listedinfo/announcement/c/2017-10-18/600267_20171018_3.pdf
1236,2017-10-18,海正药业独立董事关于第七届董事会第十九次会议部分事项的独立意见,/disclosure/listedinfo/announcement/c/2017-10-18/600267_20171018_2.pdf
1237,2017-10-18,海正药业第七届董事会第十九次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-18/600267_20171018_1.pdf
1238,2017-10-24,海正药业关于子公司获得药品补充申请批件的公告,/disclosure/listedinfo/announcement/c/2017-10-24/600267_20171024_1.pdf
1239,2017-10-31,海正药业关于召开2017年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-10-31/600267_20171031_6.pdf
1240,2017-10-31,海正药业关于拟与辉瑞方签订《调解协议》的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600267_20171031_5.pdf
1241,2017-10-31,海正药业关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600267_20171031_7.pdf
1242,2017-10-31,海正药业第七届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2017-10-31/600267_20171031_3.pdf
1243,2017-10-31,海正药业：浙江导明医药科技有限公司拟引入投资者进行增资扩股涉及的其股东全部权益投资价值资产评估报告,/disclosure/listedinfo/announcement/c/2017-10-31/600267_20171031_4.pdf
1244,2017-10-31,海正药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-31/600267_2017_3.pdf
1245,2017-11-11,海正药业关于召开2017年第四次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-11-11/600267_20171111_2.pdf
1246,2017-11-11,海正药业关于控股子公司海正辉瑞制药有限公司股权变动的提示性公告,/disclosure/listedinfo/announcement/c/2017-11-11/600267_20171111_3.pdf
1247,2017-11-11,海正药业2017年度第四次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-11-11/600267_20171111_1.pdf
1248,2017-11-13,海正药业关于收到浙江省国资委关于公司非公开发行股票有关事项的批复的公告,/disclosure/listedinfo/announcement/c/2017-11-13/600267_20171113_1.pdf
1249,2017-11-14,海正药业停牌公告,/disclosure/listedinfo/announcement/c/2017-11-14/600267_20171114_1.pdf
1250,2017-11-14,海正药业关于收到上海证券交易所对公司控股子公司海正辉瑞制药有限公司股权变动有关事项的问询函的公告,/disclosure/listedinfo/announcement/c/2017-11-14/600267_20171114_2.pdf
1251,2017-11-16,海正药业关于制剂产品吗替麦考酚酯胶囊获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2017-11-16/600267_20171116_1.pdf
1252,2017-11-16,海正药业关于延期回复上海证券交易所问询函暨公司股票继续停牌的公告,/disclosure/listedinfo/announcement/c/2017-11-16/600267_20171116_2.pdf
1253,2017-11-17,海正药业2017年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-11-17/600267_20171117_1.pdf
1254,2017-11-17,海正药业2017年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-11-17/600267_20171117_2.pdf
1255,2017-11-18,海正药业关于子公司制剂产品辛伐他汀片获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2017-11-18/600267_20171118_1.pdf
1256,2017-11-21,海正药业章程（2017年11月修订稿）,/disclosure/listedinfo/announcement/c/2017-11-21/600267_20171121_4.pdf
1257,2017-11-21,海正药业关于制剂产品吗替麦考酚酯片获得美国FDA批准的公告,/disclosure/listedinfo/announcement/c/2017-11-21/600267_20171121_5.pdf
1258,2017-11-21,海正药业关于修订《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2017-11-21/600267_20171121_3.pdf
1259,2017-11-21,海正药业关于发行超短期融资券的公告,/disclosure/listedinfo/announcement/c/2017-11-21/600267_20171121_2.pdf
1260,2017-11-21,海正药业第七届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-21/600267_20171121_1.pdf
1261,2017-11-23,海正药业关于再次延期回复上海证券交易所问询函暨公司股票停牌进展公告,/disclosure/listedinfo/announcement/c/2017-11-23/600267_20171123_1.pdf
1262,2017-11-25,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2017-11-25/600267_20171125_1.pdf
1263,2017-11-28,海正药业关于收到辉瑞补偿款的公告,/disclosure/listedinfo/announcement/c/2017-11-28/600267_20171128_1.pdf
1264,2017-11-29,海正药业关于召开2017年第五次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-11-29/600267_20171129_5.pdf
1265,2017-11-29,海正药业关于上海证券交易所对公司控股子公司海正辉瑞制药有限公司股权变动有关事项的问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-11-29/600267_20171129_6.pdf
1266,2017-11-29,海正药业关于控股子公司海正辉瑞制药有限公司股权变动涉及与辉瑞等相关方签署一系列商业合同的公告,/disclosure/listedinfo/announcement/c/2017-11-29/600267_20171129_4.pdf
1267,2017-11-29,海正药业关于控股子公司海正辉瑞制药有限公司股权变动涉及修订《合资合同》和《公司章程》部分条款和放弃优先购买权条款的公告,/disclosure/listedinfo/announcement/c/2017-11-29/600267_20171129_3.pdf
1268,2017-11-29,海正药业关于公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2017-11-29/600267_20171129_1.pdf
1269,2017-11-29,海正药业第七届董事会第二十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-11-29/600267_20171129_2.pdf
1270,2017-12-12,海正药业关于召开2017年第五次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-12/600267_20171212_2.pdf
1271,2017-12-12,海正药业2017年度第五次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-12/600267_20171212_1.pdf
1272,2017-12-14,海正药业关于召开2017年第六次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-14/600267_20171214_1.pdf
1273,2017-12-14,海正药业第七届董事会第二十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-14/600267_20171214_2.pdf
1274,2017-12-15,海正药业关于收到上海证券交易所对公司控股子公司增资及债转股事项问询函的公告,/disclosure/listedinfo/announcement/c/2017-12-15/600267_20171215_1.pdf
1275,2017-12-16,海正药业2017年第五次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-16/600267_20171216_1.pdf
1276,2017-12-16,海正药业2017年第五次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-12-16/600267_20171216_2.pdf
1277,2017-12-19,海正药业关于延期回复上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2017-12-19/600267_20171219_1.pdf
1278,2017-12-21,海正药业关于向控股子公司提供财务资助的公告,/disclosure/listedinfo/announcement/c/2017-12-21/600267_20171221_3.pdf
1279,2017-12-21,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2017-12-21/600267_20171221_2.pdf
1280,2017-12-21,海正药业第七届董事会第二十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-21/600267_20171221_1.pdf
1281,2017-12-22,海正药业关于上海证券交易所对公司控股子公司增资及债转股事项的问询函的回复公告,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_1.pdf
1282,2017-12-22,海正药业关于控股子公司浙江导明医药科技有限公司增资及债转股事项的补充公告,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_7.pdf
1283,2017-12-22,海正药业独立董事关于公司控股子公司浙江导明医药科技有限公司增资及债转股事项的独立意见,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_5.pdf
1284,2017-12-22,海正药业：浙江导明医药科技有限公司拟引入投资者进行增资扩股涉及的其股东全部权益投资价值资产评估说明,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_9.pdf
1285,2017-12-22,海正药业：浙江导明医药科技有限公司拟引入投资者进行增资扩股涉及的其股东全部权益投资价值Zhejiang DTRM Biopharma LLC资产评估说明,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_8.pdf
1286,2017-12-22,海正药业：浙江导明医药科技有限公司2017年半年度审计报告,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_3.pdf
1287,2017-12-22,海正药业：浙江导明医药科技有限公司2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_2.pdf
1288,2017-12-22,海正药业：万隆（上海）资产评估有限公司关于上海证券交易所对公司关于对浙江海正药业股份有限公司问询函之核查意见,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_6.pdf
1289,2017-12-22,海正药业：天健会计师事务所关于对浙江海正药业股份有限公司控股子公司增资及债转股事项的问询函中有关财务情况的说明,/disclosure/listedinfo/announcement/c/2017-12-22/600267_20171222_4.pdf
1290,2017-12-23,海正药业关于转让德国 IMD Natural Solutions GmbH 公司21.05%股权的进展公告,/disclosure/listedinfo/announcement/c/2017-12-23/600267_20171223_1.pdf
1291,2017-12-25,海正药业澄清公告,/disclosure/listedinfo/announcement/c/2017-12-25/600267_20171225_1.pdf
1292,2017-12-26,海正药业关于召开2017年第六次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-26/600267_20171226_1.pdf
1293,2017-12-26,海正药业2017年度第六次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-12-26/600267_20171226_2.pdf
1294,2017-12-28,海正药业关于子公司完成工商登记注册的公告,/disclosure/listedinfo/announcement/c/2017-12-28/600267_20171228_2.pdf
1295,2017-12-28,海正药业关于他克莫司胶囊未通过药品一致性评价的说明公告,/disclosure/listedinfo/announcement/c/2017-12-28/600267_20171228_1.pdf
1296,2017-12-29,海正药业关于获得中央财政专项补助资金的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600267_20171229_2.pdf
1297,2017-12-29,海正药业关于德谷胰岛素、德谷胰岛素注射液获得临床批件的公告,/disclosure/listedinfo/announcement/c/2017-12-29/600267_20171229_1.pdf
1298,2017-12-30,海正药业实际控制人关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_7.pdf
1299,2017-12-30,海正药业前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_3.pdf
1300,2017-12-30,海正药业控股股东关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_6.pdf
1301,2017-12-30,海正药业关于召开2018年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_16.pdf
1302,2017-12-30,海正药业关于使用部分闲置募集资金进行现金管理的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_13.pdf
1303,2017-12-30,海正药业关于更换公司监事的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_15.pdf
1304,2017-12-30,海正药业关于更换公司董事的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_12.pdf
1305,2017-12-30,海正药业关于非公开发行股票摊薄即期回报对公司主要财务指标的影响及采取措施的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_11.pdf
1306,2017-12-30,海正药业独立董事关于第七届董事会第二十五次会议部分事项的独立意见,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_9.pdf
1307,2017-12-30,海正药业董事、高级管理人员关于公司填补回报措施能够得到切实履行的承诺,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_5.pdf
1308,2017-12-30,海正药业第七届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_10.pdf
1309,2017-12-30,海正药业第七届董事会第二十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_8.pdf
1310,2017-12-30,海正药业：前次募集资金使用情况报告鉴证报告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_4.pdf
1311,2017-12-30,海正药业：安信证券股份有限公司关于浙江海正药业股份有限公司使用部分闲置募集资金进行现金管理的核查意见,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_14.pdf
1312,2017-12-30,海正药业2017年第六次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_17.pdf
1313,2017-12-30,海正药业2017年第六次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_18.pdf
1314,2017-12-30,海正药业2016年度非公开发行股票募集资金使用的可行性分析报告（二次修订稿）,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_2.pdf
1315,2017-12-30,海正药业2016年度非公开发行A股股票预案（二次修订稿）,/disclosure/listedinfo/announcement/c/2017-12-30/600267_20171230_1.pdf
1316,2018-01-02,海正药业关于浙江导明医药科技有限公司增资及债转股事项的进展公告,/disclosure/listedinfo/announcement/c/2018-01-02/600267_20180102_1.pdf
1317,2018-01-04,海正药业关于公司及控股子公司通过高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2018-01-04/600267_20180104_1.pdf
1318,2018-01-16,海正药业关于召开2018年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2018-01-16/600267_20180116_5.pdf
1319,2018-01-16,海正药业关于上海证券交易所对信访投诉事项的监管工作函的回复公告,/disclosure/listedinfo/announcement/c/2018-01-16/600267_20180116_3.pdf
1320,2018-01-16,海正药业：万隆（上海）资产评估有限公司关于上海证券交易所对公司关于对浙江海正药业股份有限公司信访投诉事项的监管工作函之核查意见,/disclosure/listedinfo/announcement/c/2018-01-16/600267_20180116_4.pdf
1321,2018-01-16,海正药业：上海市锦天城律师事务所关于浙江海正药业股份有限公司实施员工持股计划的法律意见书,/disclosure/listedinfo/announcement/c/2018-01-16/600267_20180116_1.pdf
1322,2018-01-16,海正药业2018年度第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2018-01-16/600267_20180116_2.pdf
1323,2018-01-19,海正药业关于浙江导明医药科技有限公司增资及债转股事项进展的补充公告,/disclosure/listedinfo/announcement/c/2018-01-19/600267_20180119_1.pdf
1324,2018-01-20,海正药业关于收到上海证券交易所对公司控股子公司增资及债转股事项问询函（二）的公告,/disclosure/listedinfo/announcement/c/2018-01-20/600267_20180120_3.pdf
1325,2018-01-20,海正药业2018年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2018-01-20/600267_20180120_1.pdf
1326,2018-01-20,海正药业2018年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2018-01-20/600267_20180120_2.pdf
1327,2018-01-24,海正药业关于使用部分闲置募集资金进行现金管理的进展公告,/disclosure/listedinfo/announcement/c/2018-01-24/600267_20180124_1.pdf
1328,2018-01-27,海正药业关于延期回复上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2018-01-27/600267_20180127_1.pdf
1329,2018-01-31,海正药业监事会关于上海证券交易所对公司控股子公司增资及债转股事项问询函（二）相关事项发表的意见,/disclosure/listedinfo/announcement/c/2018-01-31/600267_20180131_2.pdf
1330,2018-01-31,海正药业关于上海证券交易所对公司控股子公司增资及债转股事项问询函（二）的回复公告,/disclosure/listedinfo/announcement/c/2018-01-31/600267_20180131_1.pdf
1331,2018-01-31,海正药业独立董事意见,/disclosure/listedinfo/announcement/c/2018-01-31/600267_20180131_3.pdf
1332,2018-01-31,海正药业：天健会计师事务所关于对浙江海正药业股份有限公司控股子公司增资及债转股事项的问询函（二）中有关财务情况的说明,/disclosure/listedinfo/announcement/c/2018-01-31/600267_20180131_4.pdf
1333,2018-01-31,海正药业2017年年度业绩预盈公告,/disclosure/listedinfo/announcement/c/2018-01-31/600267_20180131_5.pdf
